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ABSTRACT 
Carboxylesterases (CEs; EC 3.1.1.1) are ubiquitous enzymes responsible for the 
detoxification of xenobiotics. CEs hydrolyze carboxyl esters into their corresponding alcohol and 
carboxylic acid. Because of their biological functions, especially their roles in converting inactive 
prodrugs, such as the anti-cancer drug CPT-11, to their active metabolites, a good understanding of 
the mechanism of the hydrolysis reaction will give us a better direction for drug design. In this 
study, we used a multidisciplinary approach (computational simulation, molecular biology 
techniques and enzyme kinetic methods) to study the dynamic motions of CEs and the potential 
role of these motions in the catalytic mechanism of CEs. We used a Bacillus subtilis protein 
(pnbCE) as a model and demonstrated that the two loops in pnbCE, coil_5 and coil_21, were 
important in substrate conversion. Furthermore, we found that a C-C bond side chain rotation of 
Glu310 was a possible mechanism that the enzyme alternates between its active and inactive 
conformation. The results of these studies give us new insights about the structure-function 
relationship of CEs and therefore provide valuable information for approaches toward, for 
example, CE engineering for selected substrates or design of CE inhibitors.  
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CHAPTER 1 INTRODUCTION 
 
1.1 OVERVIEW 
Carboxylesterases (CEs; EC 3.1.1.1) are ubiquitous enzymes that hydrolyze carboxyl 
esters into their corresponding alcohol and carboxylic acid. Because of the biological functions of 
CEs, especially their roles in metabolizing various substrates including the anti-cancer drug 
CPT-11, a good understanding of the mechanism of the hydrolysis reaction will give us a better 
direction for drug design.  
In this study, we used a multidisciplinary approach (computational simulation, molecular 
biology techniques and enzyme kinetic methods) to study the dynamic motions of CEs and the 
potential role of these motions in the catalytic mechanism of CEs. The results of these studies give 
us new insights about the structure-function relationship of CEs and therefore provide valuable 
information for approaches toward, for example, CE engineering for selected substrates or design 
of CE inhibitors.  
 
1.2 CARBOXYLESTERASE 
Carboxylesterases, as their name implies, are members of the esterase family and also the 
/ fold hydrolases superfamily. They have been indentified in various organisms ranging from 
bacteria to mammals, including humans. They are responsible for the detoxification of xenobiotics 
(1). CEs metabolize a variety of substrate including esterified drugs such as cocaine (2), heroin (2), 
Ceftin (3) and also the anticancer agent CPT-11 (Irinotecan) (4). CEs also catalyze the hydrolysis 
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of other compounds, such as short- and long-chain acylglycerols and long-chain acyl-CoA esters 
(5-7). 
So far, only three CEs have been identified in humans. Among these three, the crystal 
structure of only one CE isozyme, human liver CE (hCE1), is available (8) (9). The structures of 
mammalian CEs are highly homologues with those from other organisms such as bacterial CEs. 
For example, despite that the sequence of hCE1 has only 33% identity with the bacterial B.subtilis 
CE (pnbCE) (10), as shown in Figure 1-1, there is only a 2.7 Å RMSD variation across more than 
400 residues of their crystal structures (11). The pnbCE exhibits both close structural homology 
and similar catalytic activity with mammalian CEs (12). Also, pnbCE and rCE have comparable 
activities toward the hydrolysis of o-nitrophenyl acetate (o-NPA) and CPT-11 and both enzymes 
showed reduced catalytic activity when corresponding amino acid residues were mutated (12). 
Because pnbCE is a bacterial model, it can be easily modified, expressed and purified by using E. 
coli expression systems. Therefore, pnbCE makes an excellent model system for studying the 
structure-function relationship of human CEs. 
As shown in Figure 1-1, these enzymes are structurally similar and share the / fold core. 
Their structures can be divided into three domains: the catalytic domain, the / domain and the 
regulatory domain. There are two disulfide bonds (e.g., Cys87-Cys116 and Cys274-Cys285 in 
hCE1) present in mammalian CEs, which are also conserved among many other esterases in the 
family and probably play an important role in maintaining the active conformation of these 
enzymes. 
Of the two mammalian CEs that have crystal structures, hCE1 and a rabbit CE (rCE), both 
show the active site residues are buried at the bottom of a ~22 Å gorge from the surface of the 
enzymes(8-9, 13). The active site gorge is surrounded by aromatic amino acids. It is believed that 
 3 
 
 
Figure 1-1. The alignment of x-ray crystal structures of pnbCE (PDB code: 1QE3) and 
hCE1 (1MX5) 
The blue cartoon representation structure is pnbCE and yellow structure is hCE1. They both 
belong to the / fold hydrolases superfamily. 
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the negatively charged gorge likely creates an electrostatic gradient that would pull substrates 
towards the catalytic residues (8-9, 13-14). Although the active site is buried inside this long 
gorge, these enzymes are able to metabolize such a variety of substrates, showing there must be 
considerable flexibility and tolerance associated with these enzymes, allowing them to 
accommodate and hydrolyze structurally diverse compounds.  
Previous studies of mammalian CEs proposed that there is a „side door‟ adjacent to the 
catalytic gorge of these enzymes (13) (12) (15) (16). This side door is located at the bottom of the 
substrate-binding pocket and could potentially act as an alternative opening for small substrates, 
water molecules, or an exit for products (13). Similar alternative routes to the active site are also 
observed in bovine bile salt-activated lipase and acetylcholinesterase (AChE) (13, 17-18). 
Therefore, exploring the potential role of this side door is also important for the mechanism of the 
hydrolysis by esterases and lipases.  
 
1.3 CPT-11 
CPT-11 (7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin), also 
known as Irinotecan, is an anti-cancer drug for the treatment of colorectal cancer. It was approved 
by the FDA in 1994 as a medication given to cancer patients by infusion through a vein.  
CPT-11 is a prodrug, whose structure is shown in Figure 1-2. It has to be hydrolyzed by 
CEs to its active form, SN-38, a topoisomerase I inhibitor. The inhibition of topoisomerase I by 
SN-38 causes the inhibition of DNA transcription and replication (19) and eventually leads to cell 
death.  
There is a problematic diarrhea associated with the use of CPT-11. In some cases, it may 
lead to severe dehydration. This severe side-effect is related to two human CE isozymes, human 
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liver CE (hCE1) and human intestinal CE (hiCE). Because hiCE is 60-fold more efficient in the 
conversion rate of CPT-11 than hCE1, it is believed that hiCE is primarily the enzyme responsible 
for the activation of CPT-11 (20) (14). However, the overactivation of CPT-11 to SN-38 in the 
small intestine by hiCE causes high drug concentrations to be localized in the small intestine. 
Hence tissue damage to the organ eventually contributes to the delayed severe diarrhea in patients 
(14, 21). 
 
 
Figure 1-2. The hydrolysis of anti-cancer drug CPT-11 with CE 
 
In order to reduce the side-effect associated with CPT-11, CE inhibitors might be used to 
specifically inhibit hiCE without affecting the CPT-11 activation by hCE1. Without the activation 
of the drug by hiCE, hCE1 will be able to activate the drug at a much slower rate, thereby 
increasing its half-life and reducing its toxic side-effects.  
 
1.4 MECHANISM OF SUBSTRATE HYDROLYSIS  
CE cleaves the ester bond in substrates and produces an alcohol and a carboxylic acid, 
respectively. Structurally, mammalian CEs have four Cys residues and may be involved in 
forming disulfide bonds (Cys87-Cys116 and Cys274-Cys285, residue numbers are for hCE1). 
 6 
Among these four, Cys87 is the most conserved residue in CE isozymes. A sequence and structure 
alignment of a group esterases, lipases and other / fold hydrolyses was reported based on crystal 
structure of the Torpedo California acetylcholinesterase and Geotrichum candidum lipase (22). 
Based on this structural biology study, Ser221, Glu354 and His468 form a catalytic triad and some 
neighboring residues may also be incorporated into part of an oxyanion hole, which consists two 
hydrogen bonds between the negatively charged oxygen anion (called an oxyanion) of the 
tetrahedral intermediate and N-H group of adjacent Gly residues. These hydrogen bonds are 
thought to be important in stabilizing the transition state intermediate. This catalytic triad is also 
confirmed by site-specific mutations analysis. Mutations of Ser221 to Thr221, Glu354 to Ala354 
or His468 to Ala468 greatly reduced the CE activity towards substrates. The mutagenesis study 
confirmed that Glu and His form a putative charge relay system with the other catalytic residue Ser 
(23). 
A detailed proposed reaction mechanism is shown in Figure 1-3. One important aspect of 
the mechanism is the formation of a low barrier hydrogen bond between His and Glu that 
facilitates the nucleophilic attack by the -OH group of Ser on the acyl carbonyl group of the 
substrate (24). According to this proposed mechanism, the catalytic triad in the tetrahedral addition 
intermediate is also stabilized by the low energy barrier hydrogen bond between Glu354 and 
His468. The overall reaction mechanism of hydrolysis can be divided into following steps. 
1. The formation of enzyme-substrate complex. The substrate is positioned into the 
correct orientation for reaction and the catalytic triad of CE forms the hydrogen 
bond between Glu and His.  
2. The nucleophilic attack is initiated by the oxygen atom of the hydroxyl group of Ser 
on the carbonyl carbon of the substrate.  
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3. In this conformation, it is proposed that the negatively charge carboxyl oxygen on 
the substrate is hydrogen bonded to two nearby Gly and forms an oxyanion hole. 
Then the original ester bond breaks, and the leaving group picks up a proton from 
His. 
4. The carboxyl portion of the original substrate remains bound to Ser, while the 
alcohol portion diffuses away.  
5. A water molecule comes in as an intermediate. It attacks the acyl-enzyme 
intermediate to form a second tetrahedral intermediate.  
6. Then His donates the proton back to the oxygen atom on Ser, followed by the 
release of the remaining acid product of the substrate.   
7. The acid product is diffused away and the enzyme is ready for the next catalysis 
cycle. 
This mechanism is also known as the “ping-pong” proton transfer hydrolysis mechanism, 
which is common to all the enzymes so far identified in the esterase family (11). The low energy 
barrier hydrogen bond initiates the whole reaction and is the key step to the stabilization the 
tetrahedral transition state. In the next step, this tetrahedral intermediate is disrupted by the 
removal of a proton from His. After the alcohol group diffuses away, the following deacylation 
step is essentially the reverse of the acylation step.  
 
1.5 USE OF COMPUTATIONAL METHODS IN DRUG DESIGN 
As recently reviewed by the Wadkins group, the major classes of known CE inhibitors and 
in silico drug development strategies include using the quantitative structure activity analysis 
(QSAR) approach (25). One traditional method of computationally designing enzyme inhibitors is 
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Figure 1-3. Proposed mechanism of substrate hydrolysis by CEs 
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to dock small organic molecules into the active site of the protein crystal structure in order to 
calculate the binding interaction between inhibitor and its target. However, this approach is highly 
dependent on the crystal structures and its use can be limited in practice. First of all, the crystal 
structure is not always available for an enzyme. Even if it exists, enzymes are usually crystallized 
with known inhibitors or substrate in the active site, and therefore their structures are usually in 
compact, closed conformations. Moreover, docking of known inhibitors to a crystal structure of 
acetylcholinesterase (AChE), an enzyme structurally similar to CE, failed to predict the inhibition 
constants for known AChE inhibitors (26). However, the McCammon group took a more 
successful approach by incorporating dynamic structures taken from a molecular dynamics 
simulation instead of using one static crystal structure (27). Likewise, the use of dynamic 
structures becomes very important in resolving the problem for CE as well. Because these 
enzymes are in constant motion at a temperature of 37 ºC, this approach will allow MD simulation 
to explore the dynamic conformations of the enzyme and better represent its functional 
conformations.  
In this study, both molecular dynamics simulation and normal mode analysis are used to 
investigate the possible conformational changes for CEs in order to gain a better understanding of 
structural information about this family of enzymes. In general, the substrate specificity of CEs is 
dependent on two structural features: the sizes of their active site gorge and the external opening to 
the gorge. These important parameters are calculated and measured using molecular dynamics 
simulations of CEs from rabbit, human liver, human intestine, and a bacterial CE (rCE, hCE1, 
hiCE and pnbCE, respectively), and will be discussed in detail in chapter 4. In addition, we have 
also used normal mode analyses to examine their low-frequency motions, which correspond to 
large conformational changes. The crystal structure of hiCE has not been determined, so a 
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homology model is generated to be used for this enzyme. It should be noted that earlier homology 
models of rCEs (14) based on the folding of AChE were remarkably similar to the 
subsequently-determined crystal structure; with a backbone RMSD of ~2 Å. The crystal structures 
for the other three enzymes (rCE, hCE1 and pnbCE) are available and hence computational 
analyses can be easily accomplished. However, as we mentioned earlier, like some other enzymes, 
the crystal structures containing known substrates or inhibitors have an active site that is too small 
to accommodate other known, larger substrates. For instance, the structure of hCE1 crystallized 
with a product of benzil hydrolysis becomes too close-packed to allow placement of CPT-11 in the 
same location. This issue can be resolved by allowing the enzyme structure to fluctuate by using 
MD simulation. Other regions of structural fluctuation in CEs are the loops that form a putative lid 
over the entrance to the active site gorge. Normal mode analysis shows these loop motions are 
consistent among known CE structures. They control the opening and closing of the entrance to 
CEs active sites, hence probably playing an important role in control of their catalytic activity and 
substrate selectivity.  
The combination of MD and docking has been used for development of specific inhibitors 
of AChE vs. other serine hydrolase enzymes, and hence we expect this approach has the potential 
to work for CEs as well. Coupled with 3-dimensional QSAR models as a reduced representation of 
the inhibitor binding site, these computational methods have led to the prediction of several CE 
inhibitors (25).  
The understanding of the dynamic structures of CEs will be crucial for in silico docking of 
CE inhibitors as well as for understanding the origins of substrate specificity in / fold 
hydrolases.  
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1.6 / FOLD HYDROLASES  
As we mentioned earlier, CEs belong to the / hydrolases fold superfamily. The / 
hydrolases fold was defined by their structural homology. It has been described as consisting of a 
parallel, eight stranded  sheet surrounded on both sides by  helices. The three dimensional 
structures of the fusarium solani cutinase (FsCUT) and human liver carboxylesterase (hCE1) as 
well as the structure of acetylcholinesterase (AChE) revealed a very similar topology of the central 
-helix/-sheet fold and the same three residues comprising the catalytic triad: a nucleophile (Ser, 
Cys or Asp) after , an acidic residue after 7 and an highly conserved His residue located after 
the last strand (Figure 1-4).  
According to the ESTHER database, there are 99 subfamilies in the / hydrolases fold 
superfamily. There are 54 out 99 subfamilies in which at least one protein structure is known. A 
total of 918 structures have been crystallized so far in the Protein Data Bank (PDB), containing 
coordinates of native enzymes, or complexes with inhibitors or substrates. These structures 
represent 256 different proteins in the / hydrolases fold superfamily. Although these proteins 
show little sequence homology (i.e. FsCUT has as little as 197 residues, while mouse 
acetylcholinesterase (mAChE) has 582 residues (28)), the conservation of the topology suggests 
that these proteins were diverged from a common ancestor (29).  
One of the reasons that we study CEs, pnbCE in particular, is to discuss implications of our 
results for the entire / fold family of hydrolases. Our results gave us more insight into the 
possible role of the inserted loops, outside the /folding core, in controlling hydrolysis 
mechanism and substrate selectivity.  
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Figure 1-4. Topology diagram of the / hydrolases fold. 
-helices and -sheets are illustrated as rectangles and arrows, respectively. The minimal / 
hydrolases fold is indicated in dark gray. The location of the catalytic triad is indicated in black 
dots and the corresponding amino acid code. The extra -helices insertions in front of D and E 
are indicated by dashed lines and labeled as D‟ and E‟.  
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1.7 OTHER POSSIBLE APPLICATIONS OF CES 
Our goal is to establish a fundamental understanding of the relationship between enzyme 
dynamics and substrate activity of CEs. Such an understanding would, for example, allow 
modulation of CE activity by mutation of known enzymes, resulting in enhanced substrate 
conversion (30). These mutants might be used to protect against exposure to the organophosphate 
nerve agents Sarin and Tabun that target the related enzyme acetylcholinesterase (AChE). Both 
Sarin and Tabun irreversibly inhibit AChE and result in the accumulation of acetylcholine in the 
synapses, leading to uncoordinated nerve activity and death from respiratory failure (11). The 
engineering of CEs that can catalytically inactivate organophosphates could provide effective 
prevention or early therapeutic response for exposure to these nerve agents. Other engineered CEs 
might be used for narcotic overdoses. For patients who have overdosed on cocaine, administration 
of a recombinant CE that could metabolize the drug to inactive metabolites, may be effective in 
ameliorating the toxicity associated with this agent (11). In any event, development of these 
modified enzymes would be facilitated by a fundamental understanding of the relationship 
between CE molecular dynamics and substrate activity. 
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CHAPTER 2 PRINCIPLES, MATERIALS & METHODS 
 
2.1 MD SIMULATION 
Molecular dynamics (MD) simulation is becoming one of the principal tools in the study of 
biological molecules. MD calculates the time-dependent behavior of a molecular system. MD 
simulation is widely used to obtain information about conformational changes of biomolecules on 
a time scale that is otherwise inaccessible by most other computational methods, and therefore, it is 
a useful tool in extending our understanding of biological systems. Along with other 
complementary computational approaches (i.e., normal mode analysis, to be discussed in next 
section), MD simulations have become a valuable method for investigating the dynamics of 
protein structure and function. 
The various dynamic processes of proteins have time scales ranging from femtoseconds to 
seconds. Some of the characteristic time scales of protein motions are shown in Table 2-1 (31). 
Many of these motions play critical roles in biochemical functions (32). For enzymatic systems, 
rapid and localized motions may play a role at the chemical conversion level of enzymatic 
reactions. Slower and globalized motions are associated with the conformational changes of the 
enzyme prior to the reaction.  
Using MD simulations, we are able to study both thermodynamic and time-dependent (i.e., 
kinetic) properties. Among the various applications of MD simulation, we are specifically 
interested in the role of dynamics in enzyme activity (33) (34). The connection between 
microscopic simulations and macroscopic properties can be made via statistical mechanics. In 
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Table 2-1. Time Scales for Protein Motions 
 
Biological event 
Amplitude 
(Å) 
Time  
(s) MD 
Bond-length vibration 0.01 – 0.1 10-14 – 10-13 Yes 
Rotation of solvent-exposed side chains 5.0 – 10.0 10-11 – 10-10 Yes 
Hinge bending 1.0 – 5.0 10-11 – 10-7 Yes 
Rigid-body (helix) motions 10.0 – 50.0 10-9 – 10-6 No 
Loop motions 10.0 – 50.0 10-9 – 10-5 No 
Allosteric transitions 1.0 – 5.0 10-5 – 1 No 
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statistical mechanics, one of the most fundamental concepts is the Ergodic hypothesis, which 
states that the ensemble average of a group equals the time average of an individual component of 
the group. 
The basic idea is that if the system is allowed to evolve in time indefinitely, it will 
eventually go through all possible states. Therefore, if given enough computational resources, we 
will eventually be able to generate all the representative conformations of the system.  Thus, 
experimentally relevant information concerning dynamic structures and thermodynamic 
properties may be calculated using MD simulation. Although in most cases the time scale of a MD 
simulation might not be able to uncover the entire biological process, nonetheless it allows the 
characteristics of a model to be probed.  
Molecular dynamics simulation is based on solving Newton‟s second law, F = ma. For a 
particular particle i, 
  (Equation 2-1) 
where Fi is the force exerted on the particle i, mi is its mass and ai is its acceleration. Meanwhile, 
the force can also be expressed as the gradient of the potential energy,  
 (Equation 2-2) 
Combining these two equations yields, 
  (Equation 2-3) 
Equation 2-3 can relate the derivative of the potential energy to the changes in atomic 
position as a function of time. Choice of an appropriate potential energy function to describe the 
energy landscape of the biological system becomes vital to the success of a MD simulation.  
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The general form of potential energy function, 
 (Equation 2-4) 
calculates the potential energy terms as a sum of individual terms describing deviations of bond 
lengths, bond angles and torsion angles away from their equilibrium values, plus terms that 
describe van der Waals and electrostatic interactions for non-bonded pairs of atoms. The set of 
functions used to calculate intermolecular and intramolecular interactions, along with their 
associated set of parameters, is termed a force field. In this study, we mainly used the Amber force 
field, which is introduced first here. The basic force field implemented in Amber has the following 
form (35):  
   Bond 
      Angle 
    Dihedral 
      Van der Waals 
       Electrostatic 
         (Equation 2-5) 
where r,  and  are bond length, bond angle and dihedral angle values exhibited in the current 
configuration. The 'eq' subscript represents the equilibrium, or reference, values for each of those. 
Kr, K and Vn are bond length, bond angle and dihedral angle constant, respectively. The parameter 
n is multiplicity and  is the phase angle for the dihedral angle parameters. Rij is the distance 
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between atom i and j. Aij and Bij characterize Lennard-Jones potentials. qi and qj are the partial 
atomic charges for atom i and j and   is the effective dielectric constant. The first three terms 
represent the energy involving covalently bonded atoms and the last two terms represent the 
non-bonded energy between all atom pairs that are within the cutoff range.  
According to Equation 2-3, integration of the potential energy function leads to atomic 
trajectories in space and time. The general procedural flow chart is shown in Figure 2-1.  
The initial structures are usually x-ray crystal structures whose geometry may not 
correspond to the actual energy minima used in the force field. Crystal structures usually have 
bond angles and lengths distortions, causing bad contacts and therefore high energy. Therefore, an 
energy minimization step is necessary and failure to do so may lead to instabilities when we run 
dynamics. During the energy minimization, the temperature of the system is set to 0 K and the 
minimized structure has no kinetic energy associated with it. In order to allow the biological 
system to explore its potential energy surface, a certain amount of kinetic energy will be given to 
the system by assigning an initial velocity to each atom based on an algorithm that takes random 
values from a Boltzmann distribution. At the same time, target temperature of the system will be 
set to 300 K in order to simulate an actual environment for biological systems. Since the initially 
assigned velocities will most likely give you a temperature that is off the target temperature, the 
dynamics algorithm will scale the velocities up (if Tactual < Ttarget) or scale them down (if Tactual > 
Ttarget) to adjust the difference. The temperature will be periodically checked and adjusted until the 
target temperature is reached and maintained. After equilibration dynamics, a production 
dynamics is performed. First, a small time interval t is set. Then the process of calculating the 
instant force (F) and acceleration (a), moving the atom and moving the time forward (t = t + t) 
will be repeated as long as needed. The production dynamics usually lasts at least several 
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nanoseconds. In the end, large energy profiles and trajectories files are produced. Several 
AmberTools scripts and in-house python/perl scripts are used in analyzing the results. These are 
included in the appendix section. 
 
 
Initial Coordinates
Minimize Structure
Assign Initial Velocities
Equilibration Dynamics
Rescale Velocities
Temp. Check
Production Dynamics
Analysis of Trajectories
No
Yes
 
Figure 2-1. Flow chart for MD simulation 
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2.2 NORMAL MODE ANALYSIS 
Although MD simulation is widely used for studying the motions of biomolecules, normal 
mode analysis (NMA) provides an important alternative to MD simulation because it is much less 
demanding in terms of CPU time and is able to provide information about low-frequency motions 
that usually happen on a much longer time scale. NMA of proteins is based on the hypothesis that 
the vibrational normal modes with the lowest frequencies correspond to the largest movements in a 
protein that are functionally relevant. It has been shown that some of the lowest-frequency normal 
modes of some proteins are strongly correlated with their large amplitude conformational changes 
observed upon ligand binding (36-38). The corresponding normal mode coordinates have also 
been used in studying domain motions of proteins to analyze their molecular dynamics trajectories 
(39-41). 
Historically, normal mode analyses of proteins were limited to small proteins due to the use 
of all-atom description of the biosystem, empirical force fields, and the requirement of the 
minimization process. These requirements made it computationally difficult with a large system 
size. However, in recent years, some advanced techniques have been developed and dramatically 
reduced the computational expenses for NMA (40, 42-45). The most important improvement is the 
use of anisotropic network model (Hookean potential) (46). Along with a reduced representation 
of protein models (e.g. using C atoms to represent each residue of a protein), this model 
eliminated the energy minimization step, reduced the computational expenses of large protein 
systems dramatically, and eventually made it possible to set up online NMA servers (47) 
Normal mode calculation is based on the harmonic approximation of the potential energy 
surface near a minimum energy conformation. This approximation is one of the most important 
concepts in molecular mechanics because it allows a simple analytical solution to an oscillating 
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system. For proteins, their dynamic motions can be seen as a superposition of normal modes, 
fluctuating around a local minimum energy conformation (e.g. x-ray crystal structure). Most of the 
amplitude of the atomic displacement is associated with the lowest-frequency normal modes. In 
general, the solution of the equations can be solved by diagonalizing the Hessian matrix (the 
mass-weighted second derivatives of the potential energy matrix). The eigenvectors of the matrix 
are individual normal modes, and the eigenvalues are the squares of their corresponding 
frequencies. Traditionally, normal mode analysis is performed using detailed empirical force field 
such as Amber (48) or CHARMM (49). There are a few factors limiting the size of the system 
using these traditional all-atom force field approaches. First, since the size of the Hessian matrix 
that has to be diagonialized is 3Nx3N, where N is the number of atoms in the system. This 
diagonalization process is time-consuming and has been the limiting step in normal mode analysis. 
Second, an energy minimization step is required in advance to obtain a structure where the 
harmonic approximation is valid. Furthermore, typically the minimization is performed in the 
absence of any solvation models and a gas-phase minimum is usually not a reliable representative 
of a solution-phase structure as found in most biological systems. However, a new description of 
the potential energy has been introduced for normal mode analysis that has several advantages 
allowing for overcoming the limiting factors in all-atom force field approaches. It is a form of a 
single-parameter Hookean pair-wise potential, which was shown to generate low-frequency 
normal modes as accurate as those obtained with traditional force fields (46), 
   (Equation 2-7) 
where dij is the distance between two atoms i and j, dij
0
 is the distance between the atoms in the 
original input structure, c is a spring constant of the Hookean potential, which is assumed to be the 
same among all types of atom-pairs and Rc is an arbitrary cut-off (it is set to 8 Å in most cases), 
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beyond which pair-wise interactions are not taken into account. This approximation assumes that 
the reference structure represents the minimum energy conformation, so no energy minimization 
step is required. Moreover, this Hookean potential eliminates the differences between interacting 
atom-pairs by using the same spring constant and long-distance interaction are neglected as well 
by assigning the cut-off distance Rc. Although these approximations tend to break down at high 
frequencies, they are shown to have little influence on the lowest-frequency normal modes, which 
corresponds to most biologically relevant conformational changes (46) (50) (51).  
The original elastic model (46), along with later introduced Gaussian Network Model 
(GNM) (52-54) further reduced the computational cost of normal mode analysis. First, this model 
used C to represent all the residues in the protein and then replaced the interactions between 
residues in close distance with springs. Furthermore, the introduction of the building block 
approximation (also known as „rotation-translation-block‟, RTB model), groups several 
neighboring residues into single super-residues. Instead of using the transitional Cartesian 
coordinates, the rigid-body rotations and translations of the super-residue are used in GNM 
calculations. Again, for large proteins, the use of super-residue block instead of single residues is 
expected to have little impact on the lowest-frequency modes (51). 
The normal mode calculations used in these studies are carried out on the ElNémo web 
server (55). This server provides a web interface that utilizes the Elastic Network Model and the 
RTB approximation to compute and analyze lowest-frequency normal modes for biomolecules. 
The principle input structure is in Protein Data Bank (PDB) format. The calculation is done by 
constructing the interaction matrix for the elastic network model and computing its 100 largest 
eigenvalues (lowest frequencies) and their corresponding eigenvectors (normal modes). For each 
individual mode, the degree of collectivity of its movement and the mean square displacement of 
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all residues is generated.  
In ElNémo, the concept of degree of collectivity (scales from 0 to 1) means the fraction of 
residues that are significantly affected by a given normal mode. For collective movements that are 
thought to relate to functional conformational change of the protein (51), the degree of collectivity 
tends to be close to one, whereas for localized motions where the normal mode movement only 
involves few atoms, the degree of collectivity approaches zero. While low-frequency normal 
modes are expected to have collective characters, because of the nature of the calculation, 
computed low-frequency normal modes sometimes happen to be localized and therefore have a 
low degree of collectivity value. These motions, as often observed in crystallographic protein 
structures for N- or C-terminal of the protein, usually have no significant biological impact and can 
be ignored. In this study, only the low-frequency normal modes with relatively high degree of 
collectivity are considered for analysis.  
ElNémo also calculates the displacement R value for each residue of the protein in a 
individual normal mode. B-factors can be calculated from R2 by using the relationship B = 
(82/3)*R2 and linearly scaled to the observed B-factors in x-ray crystal structures. The 
comparison between calculated and observed crystallographic B-factors is a measurement of how 
well the normal modes are representing the protein‟s flexibility in its crystal environment.  
Normal mode analysis combined with a simplified representation of protein model has 
shown to be a powerful tool for the study of dynamic properties and conformational changes of 
biological systems. In this particular study, we used NMA to identify the flexible regions of our 
protein structures and planned our molecular biological and enzyme kinetic experiments according 
to these findings. Combined with experimental approaches, NMA helps us get a better 
understanding of the structure-and-function relationship of our protein system. 
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2.3 SITE-DIRECTED MUTAGENESIS 
We proposed that the flexible loops are incorporated into catalytic mechanism of CEs by 
using both MD simulation and NMA. In the next step, mutation study of these loops is designed to 
test this hypothesis. 
Site-directed mutagenesis using oligonucleotides was first introduced in 1978 (56) and its 
pioneer, Michael Smith, shared the Nobel Prize in chemistry in 1993 with the inventor of PCR, 
Kary B. Mullis (57). The basic idea is the use of PCR-based mutagenesis protocol to create 
point-mutation, deletion or insertion on the original DNA template. Because of the exponential 
growth nature of PCR, after a number of thermal cycles, a significant amount of mutated DNA 
fragment or plasmid will be generated. After either getting rid of the original DNA template or 
purifying the PCR product from the reaction mixture using gel electrophoresis, the resulting 
mutated DNA can be processed with other recombinant molecular biology methods.  
In this study, all the deletion and insertion mutants are generated by using the Phusion 
site-directed mutagenesis kit (FINNZYMES). It is one of the standard PCR-based site-directed 
mutagenesis protocols; however, it uses uncomplimentary primer pairs as opposed to the 
complimentary primer pair approach (such as the QuickChange site-directed mutagenesis kit from 
Stratagene). For plasmid manipulations, the main difference is that QuickChange approach 
generates a nicked, circular DNA with a linear amplification rate, while Phusion approach 
generates a linear DNA with an exponential amplification rate.  
The target of the site-directed mutation is the pnbCE gene that is cloned into the BamHI 
restriction site of the pTriEx-3 vector (Novagen). The PCR amplification of target plasmid follows 
the general procedures of PCR. However, the primers are phosphorylated at the 5‟ ends to 
eliminate the need for a separate phosphorylation step before ligation. The primers designed for 
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this protocol are uncomplimentary primer pair, so the reaction product is a blunt-end linear DNA 
fragment. Since plasmid DNA has a much higher transformation efficiency comparing with linear 
DNA, a ligation step is required in order to circularize the PCR product. A list of primers used in 
this study is shown in Table 2-2.  
1. Incubate the PCR product with DpnI restriction enzyme overnight at 37 ºC to 
destroy all the original template plasmid. Then purify the linear PCR product from 
an agarose electrophoresis gel by cutting the band at the right size.  
2. Circularization of the mutated PCR product by using Quick T4 DNA ligase (New 
England Biolabs). 
3. Transformation into OrigamiB(DE3)pLacI E. coli cells. 
4. DNA plasmid is purified by electrophoresis. 
5. Expression and purification of the mutated proteins. 
The detailed descriptions of PCR, restriction digestion, ligation, gel electrophoresis and 
other experimental methods are discussed in the following sections.  
 
 
Table 2-2. The list of primers used in this study 
 
Name Sequence 
[coil_5]del-F 5‟(phosphate)-CGCCAGTCCGAGGATTGCTTG-3‟ 
[coil_5]del-R 5‟(phosphate)-AGACGGCTGCGGGCAAATAGAG-3‟ 
[coil_21]del-F 5‟(phosphate)-ATTACGGATGAGGTGAAACAGCTTTCTC-3‟ 
[coil_21]del-R 5‟(phosphate)-CAATCCGTCCAGATTTCCAAAGAC-3‟ 
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2.4 POLYMERASE CHAIN REACTION 
The polymerase chain reaction (PCR) is a molecular biological technique to amplify a 
specific region of DNA across several orders of magnitude, generating a large amount of copies of 
a particular DNA sequence. Since its introduction in 1985 (57-58), the development of PCR 
method has had a major impact in the way molecular studies are carried out in research 
laboratories. The PCR method is based on thermal cycling, meaning cycles of repeated heating and 
cooling of the DNA sample and polymerase replication of the DNA sequence. Both primers and 
polymerase are the key components of the PCR reaction. As the reaction progresses, the generated 
DNA product is used as a template for the next reaction cycle, so that the DNA template is 
exponentially amplified.  
The variants of typical PCR can be used to perform a wide array of applications in 
molecular biology, including DNA sequencing, cloning/sub-cloning of cDNA, generic screening 
and site-specific mutagenesis.  
A typical PCR set up requires several components, including: 
 DNA template: A DNA sample that contains the region to be amplified. 
 Two primers: short nucleotide oligos that contain sequences complementary to the 
target region of the DNA template. In this study, we used the Phusion mutagenesis 
kit that has the uncomplimentary/phosphorylated primer pair design.  
 DNA polymerase: Typically, a thermostable polymerase is used. Phusion Hot-start 
High Fidelity polymerase (Finzymes) is used in this study. 
 Deoxynucleoside triphosphates (dNTPs): The building blocks from which the 
DNA polymerase synthesizes new DNA strands. 
 Divalent ions: Mg2+ or Mn2+ is usually used in PCR-mediated DNA mutagenesis. 
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 Reaction buffer: Usually reaction buffer is provided to create a stable environment 
for polymerase and optimum chemical environment for the reaction.  
The PCR is usually carried out in a reaction volume of 20~100 µL in PCR tubes in a 
thermal cycler. Most PCR tubes are specially designed thin-walled reaction tubes that have 
optimal thermal conductivity to allow for rapid thermal equilibration. Typically 20 to 40 repeated 
thermal cycles are performed. A detailed PCR procedure is illustrated in Figure 2-2 and described 
below: 
 Initialization step: This reaction is heated to a temperature of 95~98 ºC and is held 
for 30 seconds to 3 minutes prior to the thermal cycle.   
 Denaturation step: This is the first step in the thermal cycle which consists of 
heating the reaction to 95~98 ºC for 10 to 30 seconds.  It disrupts the hydrogen 
bonds between complementary base pairs, causes the melting of DNA template and 
yields single-stranded DNA.  
 Annealing step: Annealing temperature is one of the most important parameters in 
PCR experiment. After the denaturation, the reaction temperature is lowered to 
50~72 ºC for 20 to 40 seconds. It allows the annealing of the primers to the 
single-stranded DNA template to form the 5‟ end of the complementary strand of 
the template. The exact annealing temperature used in one particular PCR 
experiment is determined by the melting temperature of the primer pair, which is 
affected by the number of complementary base-pairs between the template and 
primer, primer C/G composition, primer concentration, salt concentration and 
many other factors. There are several equations used for calculating the empirical 
melting temperature of a DNA duplex. For example, the Nearest-neighbor method 
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(59) is one of the commonly used equations for estimating the melting temperature 
of a primer, 
 (Equation 2-8) 
where H and S are the standard enthalpy and entropy, respectively, for the 
formation of the DNA duplex from two single-stranded DNA. C1 is the initial 
concentration of the primer and C2 is the initial concentration of the original DNA 
target strand. R is the gas constant (1.987 cal/mol K).  
 Extension step: Usually 72 ºC is used in this step for most polymerases. In the 
extension step, the DNA polymerase adds dNTPs to the complementary strand in 
the 5‟ to 3‟ direction by condensing the 5‟-phosphate group of the dNTPs with the 
3‟-OH group at the end of extending DNA strand. The extension time is usually 
determined by the length of the DNA sequence to be amplified. It is also depended 
on the type of polymerase used. 30 seconds per 1k base-pairs is usually a good 
estimation for the Phusion Hot-start HF polymerase. 
 Final extension: After repeating the previous three steps for 20 to 40 times in a 
thermal cycle, a final extension step is performed at 72 ºC for 5 to 15 minutes to 
ensure all the remaining single-stranded DNA is fully extended.  
 Final hold: Hold the temperature at 4 ºC for indefinite time to allow temporary 
storage of the reaction. 
After the thermal cycle, a DpnI digestion reaction is used to get rid of the original DNA 
template. DNA samples purified from most E. coli. strands are methylated, while PCR generated 
DNA products are not methylated. Since type IIM restriction endonucleases, such as DpnI, are  
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Figure 2-2. Schematic steps of the PCR cycle 
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able to recognize and cut methylated DNA, they can be used to destroy the original DNA template 
without affecting the newly synthesized PCR product.  
The post-digestion product of PCR experiment can be checked by running an agarose 
electrophoresis gel along with a DNA ladder. A new band with the target molecular weight is 
expected from the gel.  
 
2.5 RESTRICTION DIGEST 
The discovery of restriction endonucleases is a breakthrough in the development of 
molecular biology (60) (61). As part of the natural bacterial machinery, these restriction 
endonucleases cut double stranded DNA at restricted sites.  These enzymes provide us an 
important tool to study and manipulate DNA by generating DNA fragments consistently at certain 
sequence sites.  
For each restriction enzyme, its recognition sequence produces difference in the length, 
sequence and strand orientation of digestion products.  For example, EcoRI digestion produces 
“sticky” ends, 
 
Whereas Smal digestion produces “blunt” ends, 
  
 There are four classes of restriction endonucleases: types I, II, III and IV. They all 
recognize specific DNA sequences and differ in their subunit composition, cleavage position and 
cofactors.  
 An example of restriction digestion protocol used in this study is shown here, 
1. 10x reaction buffer 5 L 
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100x BSA  0.5 L 
DNA sample  5 L 
ddH2O   39.5 L 
2. Add 1 L of restriction enzyme. Mix thoroughly.  
3. Incubate at 37 ºC for 1 hour.  
4. Verify the digestion product by gel electrophoresis and purify the linear product 
using a gel extraction kit.  
A list of restriction endonucleases that are used in this study is shown in Table 2-3. 
 
Table 2-3. The list of restriction endonucleases used in this study 
 
Enzyme Sequence Cutting site 
BamHI GGATCC 
5'- G  GATCC -3‟ 
3'- CCTAG  G -5‟ 
XhoI CTCGAG 
5'- C  TCGAG -3‟ 
3'- GAGCT  C -5‟ 
DpnI GATC (methylated) 
5'- GA  TC -3‟ 
3'- CT  AG -5‟ 
 
 
 
2.6 GEL ELECTROPHORESIS 
Gel electrophoresis is a technique used for separating a mixture of DNA, RNA or protein 
molecules through a gel matrix in an electrical field.  The gel material is a cross-linked polymer 
allowing for the separation of macromolecules. The composition and porosity of the gel is decided 
by the size and composition of the macromolecules to be separated and analyzed. Most DNA 
analyses use agarose as the gel matrix while protein separations usually use different 
concentrations of acrylamide and a cross-linker as the gel matrix.  
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By applying an electric field to the molecules in the gel matrix, the electromotive force 
(EMF) will move the sample molecules based on their charge and mass. For DNA molecules, 
because they are naturally negatively charged by their sugar-phosphate backbone and their charge 
to mass ratio is roughly the same, they will migrate in agarose gel from the cathode toward the 
anode based at different speeds based on their mass.  
Unlike DNA, the shape and natural charge of protein molecules varies. Protein samples 
with the same mass will migrate at different rates in an electric field. Therefore, they have to be 
denatured with sodium dodecyl sulfate (SDS) to be uniformly negatively charged. Since the 
binding of SDS to protein ratio is proportional to the protein size (1.4g of SDS per 1g of protein), 
the rate at which the denatured proteins migrate in the polyacrylamide gel is only related to its size. 
This gel electrophoresis technique is called sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). 
After the gel electrophoresis is completed, the separated molecules in the gel can be 
visualized after a staining process. In this study, ethidum bromide is mostly used for DNA analysis 
and coomassie brilliant blue is used for protein analysis. Upon binding with DNA or protein 
molecules, an ethidium bromide molecule fluoresces under ultraviolet light and results a visible 
band in contrast with the background. A photograph of the gel can be taken under ultraviolet light 
conditions for qualitative/quantitative analysis.  
There is usually a ladder (molecular weight maker) run parallel to the analyte molecules. 
This ladder contains a mixture of molecules of known sizes. Because the rate of migration is 
proportional to the size of the molecule, the ladder can be used to compare with the unknown 
molecules to estimate their molecular weight.  
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2.7 LIGATION 
The process of joining linear DNA fragments together through covalent bonds is called 
ligation. It is widely used in molecular biology laboratories for recombining fragments of DNA 
into new DNA molecules. Specifically, DNA ligation creates a phosphodiester bond between the 
3‟-OH end of one nucleotide and the 5‟-phophate end of another nucleotide.  
The enzyme used in ligation is T4 DNA ligase, which was originally isolated from the T4 
bacteriophage (62). With ATP in the reaction, T4 DNA ligase is able to recombine both sticky and 
blunt ends (see section 2.4 restriction digest). However, higher enzyme concentration and longer 
reaction time is required for blunt ends ligation.  
An example of restriction digestion protocol used in this study is shown here, 
1. 10x ligation buffer 5 L 
DNA sample  10 L 
ddH2O   35 L 
2. Add 1 L of T4 ligase (with a optimal concentration of ATP). Mix thoroughly.  
3. Incubate at 16 ºC for 1 hour.  
4. Take ligation product directly to transformation without heat inactivation (heat 
inactivation dramatically reduce transformation efficiency).  
 
2.8 TRANSFORMATION & EXPRESSION 
The ligated circular plasmid DNA needs to be transformed into cells in order to express its 
corresponding protein. We used the Origami B(DE3)pLacI  host strain (EMD), which are derived 
from a lacZY mutant of BL21 to enable precise control of expression. The lacZY deletion mutant of 
BL21 enables adjustable levels of protein expression throughout all cells in a cell culture. Its lacY 
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mutation allows uniform entry of IPTG into all cells in the population, which produces a 
concentration dependent, homogeneous level of induction. By adjusting the IPTG concentration 
added to a culture, expression can be regulated from low levels up to robust, fully induced levels.  
In order to be stably maintained in the cell, a plasmid DNA molecule must contain an 
origin of replication, which allows it to be replicated in the cell independent of the replication of 
the cell's own chromosome. Because transformation usually produces a mixture of relatively few 
transformed cells and an abundance of non-transformed cells a method is needed to identify the 
cells that have acquired the plasmid. The method usually consists of using a plasmid that contains 
a gene that gives the bacterial cells resistance to an antibiotic that they are naturally sensitive to. 
The cells are then plated on media that contains the antibiotic; thus only the transformed cells are 
able to grow. Cells that did not take up the plasmid are killed in the media. 
In this study, the pnbA gene is originally inserted into the pTriEx-3 vector (EMD), which is 
a vector specially designed to be compatible with Origami B(DE3)pLacI  expression system. The 
pTriEx-3 vector is a high copy plasmid and has three antibiotic resistant genes (kanamycin, 
tetracycline and chloramphenicol).  
The detailed transformation & expression protocol is also listed here, 
1. Thaw a 20 L aliquot of Origami B(DE3)pLacI  cells on ice for 2~5 minute. 
2. Add 5 L ligation product into the cells. Mix thoroughly by gently shake the tube a 
few times. 
3. Incubate on ice for 10 minutes. 
4. Incubate the tube at 42 ºC for exactly 30 seconds. 
5. Sit on ice for 2 minutes. 
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6. Add 80 L room temperature SOC media to the tube and incubate at 37 ºC with 
shaking at 250 rpm for 1 hour. 
7. Plate the cell culture on a SOC agar plate with the appropriate antibiotic 
concentrations (15 μg/ml kanamycin, 12.5 μg/ml tetracycline and 34 μg/ml 
chloramphenicol, respectively).  
8. Incubate 12~16 hours at 37 ºC.  
9. Pick ~10 colonies from the agar plate and grow 5 mL cell cultures in SOC media 
with antibiotics. Incubate at 37 °C with shaking at 250 rpm to an OD600 of 
approximately 0.5. 
10. Save 1 mL culture from each sample and then induce the reminding 4 mL cultures 
with IPTG and grow them for another 3 hours.  
11. Spin the cultures for 15 minutes at 6k rpm and process the cell pellet with 
Bugbuster (Novagen).  
12. Spin the culture for 20 minutes and collect the supernatant.  
13. Perform a CE assay with o-NPA as the substrate for CE screening. The samples 
with CE activity will proceed to the protein purification step with the saved 1 mL 
cell cultures. 
 
2.9 CE ASSAY 
A spectrophotometric assay was used in determining CE activities. Generally, a constant 
amount of protein sample was incubated with 3 mM of o-NPA, as the substrate, in 50 mM HEPES 
buffer (pH 7.4). The changes in absorption per minute were measured spectrophotometrically at 
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420 nM using a Cary-4 UV-VIS spectrophotometer. The CE activities were expressed as 
micromoles of o-NP produced per minute per milligram of CE. 
 Negative control was performed by using the pTriEx-3 vector by itself. After going 
through the transformation and expression protocol described previously, the negative control 
shows no detectable CE activity.  
 
2.10 PROTEIN PURIFICATION 
We used Isoelectric Focusing (IEF) as the primary protein purification method in our 
study. It is a technique for separating proteins based on their isoelectric point (pI) value.  
When a protein is in a pH region below its pI value, it will be positively charged and so will 
migrate towards the cathode. However, as it migrates through a gradient of increasing pH, the 
protein's overall charge will keep decreasing. When the protein reaches the pH region that 
corresponds to its pI, it has no net charge and stops migrating. As a result, the proteins become 
focused into sharp stationary bands with each protein positioned at a point in the pH gradient 
corresponding to its pI. The IEF technique is capable of extremely high resolution with proteins 
that differ in pI value by as little as 0.01. 
Our protein crude extractions are dialyzed overnight in 10 mM HEPES (pH7.4) buffer to 
get rid off the salt in protein solutions. Then the protein samples are distributed over a pH gradient 
medium that is created by ampholytes (Bio-Rad). Wild type pnbCE has a pI of ~4.7 and are 
focused in pH 3~5 ampholytes, while the mutants are focused in different pH ampholytes based on 
their individual pI values. By applying an electric current to the IEF camber, proteins start 
migrating to their corresponding pI regions. The whole process takes about 5 hours to finish. After 
collecting the protein samples into 20 fractions, a CE assay is used to identify the fractions that 
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contain our enzyme.  The right fractions are pooled together and dialyzed in 10 mM HEPES 
(pH7.4) to get rid of small molecular weight ampholytes. The protein concentrations are 
determined by Bradford assay and their purities are confirmed with SDS-PAGE gels. The purified 
protein samples are stored in 4 °C for kinetic study.  
 
2.11 BRADFORD PROTEIN ASSAY 
The Bradford protein assay is a simple and accurate procedure to determine concentration 
of solubilized protein (63). It involves the addition of protein solution with an acidic dye and 
measurement at 595 nm with a spectrophotometer. By comparing to a standard curve, the 
measurement provides an estimation of protein concentration.  
The dye reagent used in this study (Bio-Rad) is a mixture of dye, phosphoric acid and 
methanol. Among these components, Coomassie Brilliant Blue G-250 provides the maximum 
absorbance spectrum which was historically held to be at 595 nm. The dye primarily binds to basic 
and aromatic amino acid residues (64) and the extinction coefficient of the dye-protein complex 
solution is constant in a certain concentration range (65). Thus, Beer‟s law can be applied for an 
accurate quantitative measurement of the protein concentration. 
The bovine serum abumin (BSA) is used as the protein standard and the procedures of the 
assay include: 
1. Prepare dye reagent by diluting one part Bio-rad protein dye concentrate with four 
parts distilled water.  
2. Prepare 1mg/mL BSA stock solution and prepare 5 standard solutions with the 
1mg/mL BSA stock, covering the linear range of 0.2 to 0.9 mg/mL. 
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3. Pipet 100 L of each standard solution, along with the protein sample solution, into 
a test tube.  
4. Add 5 mL of the diluted dye reagent to each tube. Vortex and incubate at room 
temperature for more than 5 minutes but less than 1 hour.  
5. Measure absorbance at 595 nm. 
6. Plot the absorbance reading of the 5 standard solutions versus their concentrations. 
These 5 data points are expected to fall into a linear relationship.  
7. Based on this standard curve and the absorbance measurement of protein sample, 
calculate the concentration of the protein solution. 
Every sample is assayed in triplicate. All the protein concentrations in this study are 
measured and calculated using Bradford protein assay. 
 
2.12 ENZYME KINETICS 
The study of enzyme catalyzed chemical reactions is called enzyme kinetics. It is usually 
done by measuring the reaction rates and the effects of varying reaction conditions. In this way, the 
catalytic mechanism of the enzyme may be revealed. Since we are especially interested in the 
effects of structural dynamics of pnbCE on its substrate selectivity and catalytic activity, our 
approach involves changing some flexible features of the enzyme and monitoring their effect on 
the kinetics. By comparing these data with the wild-type pnbCE, we should get a better idea of the 
role of these flexible loops of the enzyme in substrate selectivity catalysis.   
Previous studies suggested that the hydrolysis of o-nitrophenol acetate by pnbCE exhibits 
standard Michaelis-Menten kinetics (12). This is a simple kinetic model where there is no 
intermediate, product inhibition or allostericity. In the Michaelis-Menten model, the enzymatic 
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reaction is assumed to be irreversible, therefore the reaction can be written as: 
 (Equation 2-9) 
With the pseudo-steady-state hypothesis and the assumption that the total enzyme 
concentration does not change, the initial reaction rate v0 can be expressed as, 
 (Equation 2-10) 
where v0 is the initial reaction rate,  Vmax is the maximum rate, [S] is the substrate concentration 
and KM is the Michaelis constant. Equation 2-10 can also be converted to, 
  (Equation 2-11) 
To determine the kinetic parameter KM and Vmax, a series of kinetic experiments are 
carried out by varying substrate concentration – [S]. Enzyme concentration is kept at constant and 
the initial rate v0 is measured during a short time period. Because [S] and v0 are the two variables 
that can be measured in the relationship, Equation 2-11 makes it easier to determine the kinetic 
constants when data points are used in a Lineweaver-Burk plot. As shown in Figure 2-3, standard 
Michaelis-Menten kinetics falls into a linear relationship where the slope of the equation is 
KM/Vmax and the interception on the y-axis is 1/Vmax. 
Although the kinetic parameters can be estimated using the Lineweaver-Burk plot, this 
method is error-prone and should not be used for accurate calculation in enzyme kinetics. In this 
study, the kinetic parameters and r
2
 values are determined by using non-linear regression with 
Prism software (Graph Pad) and Equation 2-10.  
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Figure 2-3. The Lineweaver-Burk plot of the Michaelis-Menten kinetics 
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CHAPTER 3 COMPUTATIONAL DYNAMICS OF PNBCE AND 
THEIR CONTRIBUTIONS TO SUBSTRATE ACCESS AND 
CATALYTIC ACTIVITY 
 
3.1 ABSTRACT
Carboxylesterases (CEs) are ubiquitous enzymes responsible for the detoxification of xenobiotics. 
In humans, therapeutically useful drugs are metabolized by these enzymes, including the 
anticancer agent CPT-11, the antibiotic Ceftin, and the street drug heroin. Structural dynamics of 
CEs have critical roles in the mechanism of catalytic drug activation and/or detoxification. In this 
study, both the low- and high-frequency motions of a CE from B. subtilis were examined, with 
emphasis on what individual domains of the enzyme might contribute to catalytic activity. We 
used both normal mode calculations and a 10-ns all-atom molecular dynamics simulation to 
understand catalytic consequences of structural changes within this enzyme. Our results describe 
low-frequency motions of residues in large loops that may sweep and/or keep substrate in the 
active site. The higher-frequency motions reveal atomic details of catalytic residue interactions 
during the simulation. The active site gorge diameter fluctuated from 2.0-7.8 Å, making it capable 
of accommodating a wide range of substrates. We observe bond rotation between two 
conformations of Glu310, which plays an important role in formation of a low-barrier hydrogen 
bond with the active site His399. Such a hydrogen bond would facilitate nucleophilic attack and 
stabilize the resulting tetrahedral intermediate. In moving between the two conformations, the C-C 
bond of Glu310 rotates 120° from an inactive conformation where the hydrogen bond is not made, 
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to an active conformation. We discuss the implications of our results for the entire / fold family 
of hydrolases. 
  
3.2 INTRODUCTION 
 Carboxylesterases (CEs) are ubiquitous enzymes responsible for the detoxification of 
xenobiotics. They are found in organisms ranging from bacteria to man (23, 66). In humans, 
therapeutically useful drugs are metabolized by these enzymes, which impacts upon the efficiency 
of some drug treatments (11). For example, CEs convert inactive prodrugs to active metabolites, a 
process that is essential for the biological activity of drugs such as the anticancer agents CPT-11 
and capecitabine, the antibiotics Ceftin and Vantin, as well as the illicit street drug heroin. 
However, more commonly, CEs hydrolyze many esterified drugs to inactive products that are then 
excreted. Agents such as flestolol, meperidine, lidocaine and cocaine, are all hydrolyzed and 
inactivated by these enzymes. Therefore the efficacy of esterified drugs will be dependent upon the 
distribution and catalytic activity of different CEs.  
 Both CE substrates and inhibitors of CEs show selectivity among isoforms from different 
species, despite the overall structural homology of the enzymes. Examples are given in references 
(67-73), where selected inhibition of 2 human enzymes (hiCE and hCE1) can be accomplished, 
depending on the structure of the inhibitor. Similar selectivity in the substrates for these enzymes 
has also been noted (14).
The specificity of CEs for a particular substrate or inhibitor depends on the enzyme's 
molecular structure, and importantly, on the dynamics of conformational substructures present 
within an enzyme when a substrate is bound (i.e., "conformational sampling" (74)). Structural 
dynamics of CEs, therefore, have critical roles in drug detoxification and can be studied by a 
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combination of experimental and theoretical techniques. Once a fundamental understanding of the 
relationship between enzyme dynamics and substrate selectivity is established, modulation of CE 
activity by mutation of known enzymes may allow for improvements in, and potentiation of, 
substrate conversion (30). Such mutants might, for example, be used as a therapeutic agent for 
treatment of heroin overdoses or for exposure to nerve agents such as sarin. 
 Studying the substrate and inhibitor selectivity of a CE from B. subtilis has proven it to be 
an interesting model system for understanding the contribution of enzyme dynamics to the 
substrate catalysis. The p-nitrobenzyl esterase (pnbCE) from this bacterium has a structural 
homology that is similar to the CE found in rabbit liver (rCE) (12). Further, its crystal structure has 
been determined (10), allowing for the 3-dimensional localization of specific residues. Its cloning 
and expression has made for a simple system to characterize at the molecular level the contribution 
of specific amino acid residues to both substrate selectivity and the effect of inhibitors. For 
example, an exploration of the "side door" hypothesis for substrate release by pnbCE has been 
recently performed, where the kinetics of substrate turnover are shown to be highly dependent on 
the L362 residue located at the bottom of the active site gorge (16). 
 However, to truly understand the individual residue contributions to the catalytic 
properties of an enzyme, molecular dynamics (MD) need to be taken into account. The use of MD 
in the development of enzyme inhibitors for the related / hydrolase acetylcholinesterase 
(AChE) has been recently reviewed (26) and these principles also apply to CEs. Briefly, enzymes 
are in constant motion at temperatures near 37°C and the understanding of the fluctuation is crucial 
for understanding of the interactions of the enzyme with its substrate or inhibitors. In the / fold 
hydrolase family, the active site residues are at the bottom of a ~22 Å gorge, the walls of which are 
also fluctuating. This is especially important given that, in the pnbCE crystal structure, the active 
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site gorge is too small to accommodate large substrates like CPT-11. However, the large CPT-11 
molecule is indeed a substrate for pnbCE (12). This dilemma can be resolved by structural 
fluctuations at both the active site opening as well as within the gorge. Taking fluctuations into 
consideration is particularly useful to understanding how substrates and inhibitors bind to the 
active site, and such knowledge may, in turn, lead to successful design of enzyme inhibitors (27).  
 Acetylcholinesterase has been the subject of considerable MD simulation for the reasons 
given above (reviewed in (26, 75)). In contrast, only a few studies of the MD of CEs have been 
reported (16, 76-77). Among them a short 400 ps simulation of wild type pnbCE was compared 
with two thermostable mutants (76). These authors noted that the thermostable mutants showed 
increased populations of low-frequency vibrational modes and suggested that this reflected 
concerted motions that provided stability to the native state versus the denatured state. However, 
the connection between these low-frequency motions and catalytic efficiency was not explored. It 
has become clear in recent years that dynamics have a profound influence on the catalytic 
properties of enzymes (74, 78-79). In this report, we have examined both the low-frequency and 
high-frequency motions of pnbCE, with emphasis on the question of what individual domains of 
the enzyme might contribute to the catalytic activity. We have used both a long 10-ns all-atom MD 
simulation with AMBER 8 (35) as well as normal mode calculations (ElNémo; (55)) to determine 
the largest structural changes within the pnbCE. Our results describe both distinct low-frequency 
and high-frequency motions that involve residues near the active site and the putative "side door" 
Leu362 that control entry of substrate and exit of hydrolyzed product. We review these motions 
below and discuss their potential role in the catalytic mechanisms of CEs. 
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3.3 RESULTS 
3.3.1 OVERALL DESCRIPTION OF PNBCE.  
The enzyme is an /fold hydrolase consisting of 489 amino acids and is folded into three 
domains: a regulatory domain, an / domain and a catalytic domain (10). The regulatory domain 
is comprised of helices F and the c-terminal helix (see Figure 3-1 for secondary structure 
designation). The naming scheme in Figure 3-1 is chosen to be consistent within the / fold 
hydrolase family (29). Between the regulatory domain and the catalytic domain lies the / 
domain, which is composed of 5 -helices (A-E) and 8 -sheets (1-8) adjacent to each other. 
The / fold which carries the catalytic machinery is the best-conserved structural features in the 
/ fold hydrolase family. Besides the / fold helices and -sheets, there are some excursions of 
varying length occur in each member of the family (primed (‟) in Figure 3-1 for pnbCE). Within 
the catalytic domain, three highly conserved active site residues (Ser189, Glu310 and His399) are 
located at the bottom of a ~22 Å by ~13 Å by ~18 Å cavity, which is similar to all other known CEs 
(11). In the crystal structure of pnbCE, the diameter of the active site gorge is ~3.6 Å wide, which 
would only accommodate small substrates in specific orientations. From the static crystal structure 
of pnbCE there is no clear way to understand how a large substrate like CPT-11 could be 
positioned into the gorge for hydrolysis. Both molecular dynamic simulation and normal mode 
analysis were used to explore, among other things, the flexibility of the gorge and its impact on 
substrate selectivity. Similar to the human liver CE (hCE1) structure, the flexibility and chemical 
environment of the gorge allows pnbCE to act on structurally distinct compounds (80) 
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Figure 3-1. The sequence and secondary structural assignment of pnbCE 
The secondary structures of pnbCE are illustrated with different color diagrams: green arrows are 
-sheets (1- 8), red bars are helices (A-F) and coils/turns in between (c1-c24). The naming 
scheme is chosen to be consistent within the / fold hydrolase family (29). The / fold helices 
are labeled as A, B, C, D, E and F. The helices in the excursions are primed (‟) and 
labeled as A1‟ before A; D1‟, D2‟, D3‟ before D; E1‟, E2‟, E3‟ before E and F1‟ 
before F.  
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3.3.2 NORMAL MODE CALCULATIONS 
The simplest way to attain large-scale, low-frequency motions of molecular structures is 
through normal mode analysis (NMA) (81). These are computationally simple calculations that 
show global structural changes on a residue-by-residue basis, but do not provide higher-frequency 
details (these are dealt with in the MD calculations below) (55, 82-83).  
The first five lowest-frequency vibrational normal modes for pnbCE were generated by the 
ElNémo web server (55). Two of these five modes (mode 7 and 11) with higher degrees of 
collectivity were used for further analysis since they represented two major global motions. The 
mean square displacement <R
2
> of mode 7 and 11 were calculated against the initial crystal 
structure. By using the relationship B = (82/3)<R2> (84), predicted B-factors of modes 7 and 11 
were calculated, linearly scaled, and plotted against the observed B-factor from the crystal 
structure (Figure 3-2). Overall these two normal modes exhibited a high correlation with the 
experimental B-factor. Both modes were able to present a similar overall fluctuation profile and 
identify the most flexible regions of pnbCE.  
It is an interesting dynamic feature of these low-frequency modes that all the active site 
resides (Ser189, Glu310, His399) are structurally rigid themselves. In contrast, there are several 
major flexible regions, including coil_17 and coil_20 (Figure 3-2) in close proximity to the active 
site gorge. These flexible regions constitute the "excursion" regions E' and F' in / fold hydrolase 
nomenclature (29), and are common features of large esterases. This flexibility near the active site 
allows the bottom of the gorge to expand and contract, and likely allows the pnbCE to metabolize 
a variety of substrates with different molecular sizes and chemical properties. 
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Figure 3-2. The experimental and predicted B-factors of pnbCE 
The solid grey area is the experimental B-factor from its crystal structure (PDB entry 1QE3). Red 
and blue lines are the predicted B-factors from analysis of normal mode 7 and 11, respectively. 
Predicted B-factors are scaled for comparison purpose. The colored bar under the abscissa is used 
to represent the secondary structure assignment: green arrows are ß-sheets, red regions are helices 
and yellow regions are coils and turns. The signature / fold hydrolase regions are indicated by 
A-F and 1-8.  
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Both modes 7 and 11 represent different characteristic dynamic properties of pnbCE. Mode 
7 (Figure 3-3a) was dominated by motions of two loop regions, coil_5 (residues 61-82) and 
coil_21 (residues 408-422) that are located on the surface of pnbCE. These motions correspond to 
the poorly resolved regions (residues 66-74 and 414-420) in the crystal structure, indicating their 
flexibility. The detailed dynamic correlation information will be analyzed later in dynamic 
cross-correlation map (DCCM) section. As shown in Figure 3-3a, the motions of coil_5 and 
coil_21 are not only large in magnitude but also highly anti-correlated, while the rest of the protein 
backbone is essentially rigid. These anti-correlated motions serve to form a flexible cover over the 
active site, and would necessarily restrict substrate entry. This can be seen more clearly in Figure 
4, where the views into the active site, as well as the back side of the active site, during the 
low-frequency motions of normal mode 7 are shown. The active site residues are shown in red and 
the “side door” residue Leu362 is shown in yellow in Figure 3-4. The Lee-Richards solvent 
accessible surface is shown in green. The crystal structure of the pnbCE is shown as the central 
structure.  
The extent of gorge opening and closing at the surface is completely controlled by these 
motions. Also, in the back view of Figure 3-4, there is the so-called “side door” on the molecular 
surface, which is directly blocked by Leu362. This “side door” is adjacent to the active sites and is 
about 3.0 ~ 3.5 Å in diameter, which is similar in size to the narrowest part of the active site gorge 
diameter. If the “side door” residue unblocks this hole, it could provide a possible entrance for 
water molecules or exit for small hydrolyzed products. It was indicated in previous studies (12, 16) 
that this “side door” residue Leu362 plays an essential role during pnbCE-catalyzed hydrolysis of 
substrates. Although the position of the “side door” residue Leu362 is essentially unchanged 
during its conformational change in normal mode 7, the dynamic motions of Leu362 that could  
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Figure 3-3. Normal mode analysis of pnbCE 
The ribbon-and-arrow representation of pnbCE, with red arrows indicating the displacements of 
the C atoms. The grey ribbon (backbone) and CPK (active site) representations are shown. The 
catalytic triad is shown in green, while the "side door" leucine is in blue. The regions of greatest 
displacement are labeled and indicated by the yellow section. (a) Normal mode 7. The yellow 
section serves as a “lid” over the active site. (b) Normal mode 11. Regions in yellow are close to 
the catalytic triad and contribute to the size change of the catalytic pocket. 
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Figure 3-4. The solvent accessible surface of pnbCE 
The backbone structure is grey and the active site residues are shown in red. The equilibrium 
crystal structure, open and closed forms are shown from those calculated using normal mode 7. 
The opening of the pocket changes dramatically among all three forms and consequently controls 
substrate entry and exit from the gorge.  
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possibly facilitate the opening of this “side door”, along with the fluctuations in the active site 
gorge diameter, is discussed below both in normal mode 11 and in the MD studies. 
Normal mode 11 (Figure 3-3b) indicates a second major dynamic motion of pnbCE. The 
fluctuation amplitudes of three components, E2‟ (residues 337-346), coil_17 (residues 308-323) 
and coil_20 (residues 386-401) of pnbCE are enlarged compared to mode 7, indicating a different 
aspect of dynamic information of pnbCE. In Figure 3-3b, it can be seen that these major 
differences in motions are near the bottom of the active site gorge. E2‟ and coil_17 are situated at 
the back of the active site behind the "side door” residue Leu362. One of the questions around the 
"side door" concept is how very large substrates such as CPT-11 could exit via this mechanism 
following hydrolysis to SN-38. Since E2‟ and coil_17 are located on both sides of Leu362, the 
anti-correlated motion shown in mode 11 (Figure 3-3b) allows these regions to move away from 
each other, creating a large space at the bottom of the active site gorge that would allow 
displacement of Leu362 and create a substantial exit route. This is a potential mechanism for 
opening the "side door" that would be big enough to release large hydrolysis products. 
Additionally, as part of the active site gorge, this collective motion of coil_17 may contribute 
significantly to the fluctuation of the gorge size (see MD simulation below).  
 
3.3.3 NORMAL MODE DYNAMIC CROSS-CORRELATION MAPPING.  
The amplitudes of dynamic motions are calculated by the normal mode predicted 
B-factors. The modes can also be analyzed with respect to direction by dynamic cross-correlation 
maps (DCCM) to determine which parts of the molecule behave as units. The DCCM make it 
straightforward to see how the motion of single residue is correlated with all other residues in the 
enzyme. The DCCM of pnbCE for normal mode 7 is shown in Figure 3-5a while that for mode 11 
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is shown in Figure 3-5b. A green-red color scale is used to represent the motions, with green 
indicating correlated motion and red indicating anti-correlated motion. Although, by their very 
nature, most of the motions calculated by normal mode analysis are correlated to a degree, the 
DCCM does provide information about the interconnectivity of the secondary structures and their 
dynamic relationships, which can be seen as off-diagonal crosspeaks.  
The DCCM for normal mode 7 (Figure 3-5a) indicates that the predominant correlated 
segment consists of residues 210-300, which is the region between -sheet 6 (and -helix D 
(D) of the / hydrolase fold. This corresponds to a region containing three -helices (Figure 
3-1) and is the common "excursion" location for / fold hydrolases (the region where all 
members of the family are the least homologous (29)). This region is adjacent to the opening of the 
active site gorge, and is usually the domain that is involved in substrate binding (28). While the 
magnitude of the motion in this region is not as large as the surface loop regions (Figure 3-2), the 
DCCM maps indicate that this region acts as an intact, isolated region that evolved to maintain its 
3D structure, which would be consistent with a role in substrate binding. 
One significant off-diagonal segment consists of the anti-correlated motions between 
coil_5 and coil_21, as the red arrows indicate in Figure 3-3a. Since both loops cover the entrance 
of the active site gorge, their anti-correlated motions likely plays a role in controlling the process 
of substrate entering the active site, acting as a lid over the gorge entrance. The other major 
off-diagonal segment in mode 7 consists of the anti-correlated motions of residues 210-240 and 
320-350. As part of the -helices D and E, they belong to the / domain and the regulatory 
domain, respectively. These -helices are located at the protein surface around the active site 
gorge (at the bottom of pnbCE structure in Figure 3-3a) and their anti-correlated motions would 
greatly contribute to the size fluctuation of active site gorge of pnbCE. 
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Figure 3-5. Dynamic cross-correlation maps from normal mode analysis 
These plots show correlated motions of the C atoms between all residue pairs in (a) mode 7, and 
(b) mode 11. The green-red scale color bar on the right indicates the extent of the correlation. 
Green indicates a high level of correlated motions (residue pairs move together in the same 
direction), while red indicates anti-correlated motions (residue pairs move together in the opposite 
direction). To highlight the collective motions, only motions in the top 20% of the color scale (-1.0 
to -0.8 and 0.8 to 1.0) are shown. 
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The main difference between mode 7 and 11 in DCCM is that mode 7 (Figure 3-5a) shows 
more intact and large scale collective motions, while mode 11 (Figure 3-5b) shows more 
individual secondary structure component motions. This is consistent with mode 11 representing 
the relatively higher frequency motions comparing with the lowest frequency motions of mode 7. 
In Figure 3-5b, most of the components in the /fold domain move in a correlated fashion, 
including 3, A, 4, B, 5, C, 6, D and 7. They are the central components of the 
/folding pattern of pnbCE which carries the catalytic machinery. Thus these correlated motions 
are responsible for keeping the structural and functional stability of pnbCE. 
 
3.3.4 MOLECULAR DYNAMIC SIMULATIONS.  
While NMA allows us to explore the lowest-frequency motions in pnbCE, given the simple 
empirical energy function used to analyze the motions, no timescale is available for the resulting 
motions (i.e., the simplified force constants used in NMA are not the true force constants acting on 
the atoms). Similar loop motions in other enzymes are on the micro- to millisecond time scale are 
correlated with the catalytic cycle (78) and those observed during NMA most likely are on this 
time scale as well. It was also of interest to examine high-frequency motion on the ps to ns time 
scale using molecular dynamics (MD) and force constants of greater accuracy and complexity (the 
AMBER force field). After energy minimization and equilibration of the complete pnbCE 
molecule, a 15 ns MD simulation was performed. During the simulation process, the pnbCE 
molecule reached its local minimum energy equilibrium after ~5 ns and fluctuated around 
-6651.37 ± 16.94 (mean ± sd) kcal/mol (Figure 3-6a), indicating that our model provided a 
reasonable starting structure for our simulation and was at equilibrium throughout the remaining 
10 ns (the time window used for the analysis below). 
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Figure 3-6. MD simulation of pnbCE 
(a) Total energy fluctuation in kcal/mol during 10-ns MD simulation is presented, indicating 
equilibrium sampling during the trajectory. (b) The pnbCE active site gorge diameter during 10-ns 
MD simulation. The diameter of active site gorge fluctuates between 2 Å to 7 Å and increases its 
fluctuation with time during the 10-ns MD simulation. (c) The normalized probability density 
distribution of pnbCE gorge diameter.  
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Figure 3-6b & c illustrates the gorge diameter fluctuations of pnbCE from our MD 
simulation, which is a measure of the largest substrate that can reach the catalytic active site triad. 
Overall, the average gorge diameter fluctuated at 4.05 ± 0.45 Å throughout the simulation. 
However, the diameter size collapsed to 2.0 Å at its narrowest to as large as 7.8 Å at its widest. The 
size and fluctuation of the gorge diameter increased during the simulation, from 3.81 ± 0.48 Å 
(first 2 ns) to 4.71 ± 0.85 Å (last 2 ns). These diameters are significantly larger than that reported 
for the related acetylcholinesterase (AChE) (75), where the gorge diameter fluctuations were 
found to be 3.04 ± 0.52 Å. Further, we do not see the bimodal switch in gorge diameter that was 
observed for AChE and that has been postulated to act as a gating mechanism during the 
hydrolysis of AChE substrates. This is not surprising, inasmuch as CE's are promiscuous enzymes, 
whereas the AChE is finely tuned for acetylcholine. As we have noted earlier, CPT-11 has a 
conical molecular volume, with the wider end having a diameter of 7.8 Å and the narrower end a 
diameter of 3.1 Å (14). The gorge fluctuations shown in Figure 3-6b indicate that pnbCE could 
accommodate a molecule the size of CPT-11 with little difficulty. 
 
3.3.5 ACTIVE SITE AND "SIDE DOOR" RESIDUES.  
The catalytic triad, Ser189, Glu310 and His399, is highly conserved among CEs (85). As 
noted in Figure 3-7, it is proposed that hydrolysis is initiated by nucleophilic attack of the -OH 
group of Ser189 on the carbonyl group of the substrate (24).  
According to this theory, the low barrier hydrogen bond between Glu310 and His399 
facilitates the initial nucleophilic attack by Ser189 and stabilizes the tetrahedral intermediate as 
well. Therefore the conformational change involving this Glu-His hydrogen bond is essential for 
the hydrolysis mechanism. The root mean square fluctuation (RMSF) of the active site and "side 
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Figure 3-7. Proposed catalytic mechanism of hydrolysis catalyzed by CEs 
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door" residues from MD simulation revealed interesting features of the active site residue Glu310 
and the "side door" residue Leu362. Both residues alternate between two distinctive conformations 
during the whole of the dynamic simulation. These two conformations are characterized by two 
distinct RMSF values (vs. the crystal structure); Glu310 fluctuates between positions that are 1.3 Å 
and 1.5 Å RMSF. Leu362 fluctuates between positions that are 0.7 Å and 2.1 Å RMSF. This is 
illustrated in Figure 3-8 by focusing on the 1.0 ns region between 6.0 ns to 7.0 ns. In the MD 
simulation, the conformational details are given in a snapshot at 6.5 ns that shows both Glu310 and 
Leu362 at their high-RMSF conformation, and another snapshot at 6.9 ns that shows their 
low-RMSF conformation (Figure 3-9). The two conformations are colored with green and blue to 
indicate the changes observed.  
The large RMSF changes in Figure 3-8 are caused by bond rotation in the two 
conformations. Glu310 plays an important role in formation of a low-barrier hydrogen bond with 
the His399 residue. Such a hydrogen bond facilitates nucleophilic attack and stabilizes the 
tetrahedral intermediate (24). In moving between the two conformations, the C-C bond of Glu310 
rotates 120° from an inactive conformation (blue) where the hydrogen bond is not made into an 
active conformation (green) where it is made. 
Also on this time scale, Leu362 rotates 180° around its C-C bond and adopts two distinct 
conformations, one of which moves the side chain of the Leu362 away from the active site residue 
Ser189 by an additional 1.5 Å. This conformational change would make it possible for small 
hydrolysis products to be released from the enzyme via this "side door". Although speculative, 
such a rotation as part of the catalytic cycle might also explain the catalytic effects observed in 
mutation studies of the Leu362 residue (12). Mutation of the Leu residue to Lys and Arg would 
introduce a long, bulky side chain to the residue that would constrain rotational motions and 
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Figure 3-8. The RMSF of two residues Glu310 and Leu362 with respect to their initial 
coordinates as a function of time for pnbCE 
As part of the catalytic triad, Glu310 alternates between two conformations around 1.5 Å RMSF. 
Meanwhile, the "side door" residue Leu362 also alternates between two major conformations. 
Both conformation 1 (green) and 2 (blue), as indicated by arrows, correspond to the same two 
conformations in Figure 3-9. 
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Figure 3-9. A snapshot of pnbCE from the MD simulation showing the active site Glu310 
and "side door" residue Leu362 in their two conformations 
The transparent cartoon representation in the background is the backbone of pnbCE and red arrows 
indicate the possible directions of substrate and product movement. The catalytic triad (Ser189, 
Glu310 and His399) and "side door" (Leu362) from two conformations are highlighted in green 
(6.5 ns point in Figure 3-8) and blue (6.9 ns point in Figure 3-8). The distances of the closest 
carbon atoms between Ser189 and Leu362 are shown in dotted lines. Red solid arrows are used to 
indicate the bond rotations that occur during the conformational change. 
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potentially block product from exiting this "side door". This would be especially true for large 
products, which would help to explain why the substitution of Leu with Arg or Lys inhibits 
CPT-11 metabolism 10- or 5- fold, respectively, but has modest effects on o-NPA catalysis. 
 
3.4 DISCUSSION 
 In this report, we examined the simulated molecular motions inherent in pnbCE, a 
carboxylesterase from B. subtilis. The global structure of pnbCE is that of a / fold hydrolase and 
we analyzed the dynamic motions of individual components. Our data have important implications 
for this family of enzymes and their catalytic mechanism. 
Recent experimental and computational evidence shows that fast (femtosecond to 
picosecond) dynamic motions play essential role to enzymatic transition state barrier crossing 
(79). One of the biggest advantages of MD simulation is to explore the fast dynamic motions at the 
atomic level. The side chain C-C bond rotation of Glu310 provides a possible mechanism for an 
on/off switch of the low-barrier hydrogen bond with His399 residue, which is essential in the 
proposed CE hydrolysis mechanism (24) (Figure 3-7). Also this bond rotation happens fast enough 
(200 to 300 ps) to be incorporated into the fast dynamic motions (fs to ps timescale) that links to 
transition state barrier crossing process (79).  
Although fast dynamic motions are essential in enzymatic barrier crossing, the overall 
turnover rate of the enzyme is on the microsecond to millisecond time scale. It is on the same time 
scale as low-frequency/slow dynamic motions, which are usually corresponding to loop/domain 
motions. Our normal mode analysis provides a look at the lowest-frequency, largest structural 
changes in pnbCE, which are generally correlated with catalytic activity. The loops designated 
coil_5 and coil_21 form a flexible lid over the entry to the active site gorge. These loops are 
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divergent in the / fold hydrolase family and likely help either to control which substrates have 
access to the active site gorge or which are allowed to exit once the gorge is entered. As a substrate 
approaches the enzyme, the anti-correlated motion of these loops may serve to orient the substrate 
for easier access to the active site gorge. 
 Once inside the gorge, the fluctuating walls act as a diffusion barrier to allow access to the 
catalytic triad. However, the barrier is much smaller in pnbCE as compared to other, more 
specialized members of the / fold hydrolase since the gorge diameter is much larger. This leads 
to a greater range of substrates able to arrive at the bottom of the gorge. The enzyme can then 
release larger products when E2‟, coil_17, and coil_21 move away from the active site in a 
concerted motion (Figure 3-3b) that would create a large gap in the bottom of the active site gorge. 
These regions then move back into position for hydrolysis of another substrate. 
The catalytic residues Ser189, Glu310 and His399 are located at the bottom of the active 
site gorge comprised of residues 105–108, 193, 215–216, 268–275, 310–314, 362–363, and 
399–400 (10). Coil_5 of pnbCE is located right on top of the active site gorge and, as indicated 
above in normal mode analysis, is one of the most flexible region of the enzyme. It contains the 
amino acid sequence PQPSDLLSLSYTELPRQSED between Cys
61
-Cys
82
 residues. This loop is a 
characteristic structural element that is conserved among the esterase/lipase family (22). It is 
structurally homologous to the large omega loop ( loop), Cys69-Cys96, of mouse 
acetylcholinesterase (mAChE), which was studied extensively by using both computational 
simulation and experimental measurements (86-88). It is believed that the conformational change 
of the  loop of AChE plays a crucial role in ligand binding. Among these  loop residues, Tyr72 
and Asp74, as part of the peripheral anionic site (PAS) of mAChE, bind cationic substrate as the 
first step in the catalytic pathway (14, 89-91), forming a low-affinity complex at PAS that 
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accelerates catalytic hydrolysis. It is unknown whether the same binding mechanism exists in 
carboxylesterases, but given the fact that the coil_5 of pnbCE and the  loop of mAChE are 
homologous (sequence alignment shown below),  
 mAChE 69- CYQYVDTLYPGFEGTEMWNPNRELSEDC -96 
       |.|..|.|...:  ||:   .|: |||| 
 pnbCE 61- CPQPSDLLSLSY--TEL---PRQ-SEDC -82 
both sequentially and structurally, it is likely that this loop plays a similar role in part of the ligand 
binding process of CEs.  
The conformational changes of the  loop of mAChE upon ligand binding have been 
characterized by a combination of cysteine substitution and site-specific labeling experiments 
(87-88). It was concluded from these studies that  loop residues are significantly more mobile 
than other residues around the active site gorge. Our data is consistent with this idea, and we 
observe coil_5 dominating the RMSF analysis in both of our normal mode analysis and MD 
simulation. Furthermore, the structural mobility of mAChE residues L76, E81 and E84 on the  
loop of mAChE has been studied in these experimental studies (To avoid confusion, mAChE and 
pnbCE residues are in single letter and three letter formats, respectively). Since both L76 and E84 
of mAChE are conserved in pnbCE, their corresponding residues in pnbCE Leu68 and Glu74, 
along with another polar and negatively charged residue Asp66 which is similar to E81 of mAChE, 
are selected to calculate their correlation with the active site gorge diameter fluctuation during the 
10-ns MD simulation. As shown in Figure 3-10 (a&b), three loop residues (Asp66, Leu68 and 
Glu74) are on the outer surface of the protein molecule and six gorge surface residues (Tyr109, 
Met193, Ile270, Glu310, Leu362 and His399) are located around the active site and on the solvent 
accessible surface of the active site gorge. Among them, Glu310 and His399 are part of the active 
site triad, Met193 is at the bottom of the gorge, Tyr109 and Ile270 are located on the opposite side  
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Figure 3-10. RMSD correlation study among selected residues 
(a) The top view of the active site gorge. The viewers look down the gorge into the active site, with 
the coil_5 loop region on top of the entrance of the gorge. Residues inside of the active site gorge 
are highlighted in yellow while loop residues are in red. (b) The side view of the same 
conformation as figure A. (c) The RMSD of all the residues after the 10-ns MD simulation. The 
labeled residues are used in the correlation study.  
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of the gorge away from the active site, and Leu362 is the “side door” residue. All six gorge surface 
residues are either at or near the bottom of the RMSD plot during MD simulation (Figure 3-10c), 
indicating structurally they are comparatively rigid. In contrast, coil_5 is the only region that is not 
only relatively close to the active site gorge but also possesses one of the highest RMSD values. 
Hence, the fluctuations of the distances between the three loop residues and the six gorge surface 
residues (a total of 18 vectors) provide a good measurement of the loop dynamics. A dynamic 
cross-correlation analysis between each one of the 18 vectors and the gorge diameter was 
performed. The objective of this analysis is to identify which loop residue motion is correlated 
with the open/closed motions of the gorge diameter. Table 3-1 shows distances between loop 
residue Glu74 and the gorge surface residues are highly correlated among themselves (>0.80). 
Similar correlations of Asp66 and Leu68 can be also seen (tables are not shown). These high 
correlation values mean that the loop motion involving Asp66, Leu68 and Glu74, is not only a high 
magnitude motion as the normal mode B-factor (Figure 3-2) and the MD simulation RMSD plot 
(Figure 3-10c) indicate, but also a highly-organized collective motion.  
The first row of Table 3-1 is the correlation between the gorge diameter and the six 
distance vectors involving Glu74. Along with the same correlation information involving Asp66 
and Leu68, the correlation between gorge size and three loop residues is compared in Table 3-2. 
Among all three loop residues, Glu74 shows a significant correlation (0.3 to 0.5) with the gorge 
size fluctuation. However, dynamics of Asp66 and Leu68 shows minimal correlation with the 
gorge size fluctuation despite being on the same loop (Table 3-2). We found that the correlation 
coefficient between the distance Glu74-His399 and the gorge diameter is 0.5 (Table 3-2), which is 
similar to the highest correlation coefficient between a C-C distance and gorge radius in 
previous MD simulation study of mAChE (86). This high correlation means the motion of Glu74  
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Table 3-1. Normalized dynamic cross-correlation coefficient of 6 distance vectors involving 
E74 and gorge diameter 
 
Crρ
a b 
Glu74-
Tyr109 
Glu74-
Met193 
Glu74-
Ile270
c
 
Glu74-
Glu310 
Glu74-
Leu362 
Glu74-
His399 
 1.00 0.31 0.39 0.35 0.41 0.32 0.50 
Glu74-
Tyr109 0.31 1.00 0.80 0.83 0.82 0.81 0.79 
Glu74-
Met193 0.39 0.80 1.00 0.83 0.91 0.90 0.88 
Glu74-
Ile270 0.35 0.83 0.83 1.00 0.87 0.83 0.82 
Glu74-
Glu310 0.41 0.82 0.91 0.87 1.00 0.94 0.96 
Glu74-
Leu362 0.32 0.81 0.90 0.83 0.94 1.00 0.90 
Glu74-
His399 0.50 0.79 0.88 0.82 0.96 0.90 1.00 
a
 Cr - Normalized correlation coefficient (range from -1.0 to 1.0) 
b
  - gorge diameter of pnbCE (Å)  
c
 Vector distance between two residues 
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moving away from the active site gorge facilitates the enlargement of the entire gorge, suggesting 
the open/closed conformational changes of pnbCE are controlled by the loop motion, especially 
the motion of Glu74 residue.  
The result of this analysis is consistent with the experimental observations of mouse 
Acetylcholinesterase (mAChE) (87-88). It shows that the ranking of segmental mobility of the 
three mAChE Ω loop residues is: E84 > E81 > L76, and also acrylodan modification of substituted 
cysteine at E84 (corresponding to Glu74 in pnbCE) reduces ligand binding and kinetic parameters 
over one order of magnitude; however, a similar substitution at L76 and E81 barely alters the 
kinetics (87-88). Our simulation provides a possible explanation to this experimental 
phenomenon. When a substrate approaches the enzyme, it first binds to Glu74 of the coil_5 loop in 
pnbCE (E84 of the loop in mAChE). Then this binding process facilitates conformational 
change around active site gorge, opens up the active site gorge to accommodate the substrate and 
finally allows the hydrolysis to proceed.  
In summary, we combined normal mode analysis and MD simulation to study the dynamic 
motions of pnbCE and their roles in its catalysis. Our normal mode analysis revealed two distinct 
low-frequency motions of residues in large loops near the top of the active site gorge that may 
sweep and/or keep substrate in the active site. A 10-ns MD simulation revealed higher-frequency 
motions with atomic details as to how the catalytic and loop residues interact during the 
simulation. Although, the atomic details of motion of the loop region can not be completely 
explored due to the short time scale of MD simulation, coupled with normal mode analysis, the 
collective dynamics of this loop region and the active site gorge provide a picture of how this loop 
facilitates enzymatic conformational change of pnbCE. It provides a direction for additional 
experimental studies to establish the mechanistic basis of the specific role of each residue on the 
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loop. Current mutational analysis in our laboratory is ongoing to test the biological significance of 
these loops in mutants of pnbCE. 
 
Table 3-2. Normalized dynamic cross-correlation coefficient between each of the 18 distance 
vectors and gorge diameter fluctuation 
 
Crρ Tyr109 Met193 Ile270 Glu310 Leu362 His399 
Asp66 0.01 -0.04 0.20 0.12 -0.09 0.28 
Leu68 0.07 -0.11 0.24 0.02 -0.07 0.11 
Glu74 0.31 0.39 0.35 0.41 0.32 0.50 
 
 
3.5 MATERIALS & METHODS 
3.5.1 PNBCE STRUCTURE 
The structure of B. subtilis carboxylesterase (pnbCE) was taken from Protein Data Bank 
entry 1QE3 (10). Two loops, residues 66-74 and 414-420, are missing from the crystal structure 
and were inserted using Modeller (92). The resulting structure was then minimized with respect to 
energy using the sander module of AMBER 8 (93). The secondary structure assignment of pnbCE 
was done by program STRIDE (94). Like other carboxylesterses, pnbCE is folded into three 
domains, a catalytic domain, an / domain and a regulatory domain. A total of 15 -helices, 14 
-sheets, and 25 coils and turns were assigned by the program (see Figure 3-1). 
 
3.5.2 NORMAL MODE ANALYSIS 
Normal mode analysis (NMA) was performed on the ElNémo web server (55), which is a 
web interface to the Elastic Network Model that implements the „rotation-translation-block‟ 
(RTB) approximation. The minimized starting structure was used as the input PDB file. The 
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number of residues that are treated as a rigid body value (NRBL) was determined by the server as 
a function of protein size to optimize computation speed. A cutoff of 8 Å was used to identify 
elastic interactions. The first 6 zero-frequency modes contain the overall rotations and translations 
of the system. Our focus was the 5 lowest non-zero frequency modes (modes 7-11) that were 
generated. The output of NMA is a series of trajectory files in Protein Data Bank (PDB) format, 
which include 11 structures by default: the original input structure and ten frames representing the 
motions between the two conformational extrema of the normal mode. 
Modes 8, 9 and 10 have a low degree-of-collectivity value around 0.1, which meant only a 
few atoms were involved in these motions. Additionally, the motions were all localized within the 
N- or C-termini of the structure. For the purpose of analyzing structural and functional 
relationship, these modes were ignored due to the lack of global conformational significance. 
Meanwhile, modes 7 and 11 had high degree-of-collectivity values of 0.24 and 0.34, respectively. 
These two modes were used for further analysis. 
The mean square displacement <R2> of all C- atoms in mode 7 and 11 were calculated 
from comparison with the input structure. By using the relationship B = (8 2/3)<R2>, predicted 
B-factors were calculated for both normal modes (43). Both <R2> and predicted B-factors are 
arbitrary numbers, and can be linearly scaled for comparison purpose. The experimentally 
observed B-factor was obtained from the x-ray crystal structure of pnbCE. In Figure 3-1, both 
predicted B-factors were scaled and plotted with the real B-factor, providing a measure of how 
well the protein's fluctuation in the crystal structure was represented by these two low-frequency 
normal modes. 
Cross-correlation analysis was performed on all the residue pairs in pnbCE for mode 7 and 
11, respectively. The cross-correlation coefficient Cij, between atoms i and j, was computed as 
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follows: 
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    (Equation 3-1) 
where Ri and Rj are the displacement vectors for atom i and j, respectively and the brackets 
indicate an average over the trajectory. The value of Cij was calculated using an in-house python 
program. Input of the program is the trajectory file (in PDB format) that was generated by ElNémo 
server. The result was loaded into a 489 x 489 matrix and the value of Cij ranged from –1 (fully 
anti-correlated, residue pair moving in the opposite direction) to 1 (fully correlated, residue pair 
moving in the same direction). In Figure 3-4, only the top 20% of the correlated motions are shown 
in these dynamic cross-correlation maps (DCCM). 
Active site pocket identification and measurements were done on CASTp server (95). The 
weighted Delaunay triangulation and the alpha complex are used for shape measurements (96). 
The calculation used default atomic radii and a solvent probe of radius 1.4 Å. Measurements for 
both solvent accessible surface (Lee-Richards' surface (97) ) and molecular surface (Connolly's 
surface (98)) were calculated by the server. 
 
3.5.3 MOLECULAR DYNAMICS SIMULATIONS 
MD simulations were performed with the AMBER 8 software suite using the ff94 force 
field (48) and the pairwise generalized Born model (99). Energy was minimized for 100 cycles of 
2 fs and followed by a 10 ps equilibration cycle, with positional restraints on all atoms. 
Temperature of the system was gradually increased from 0 K to 300 K during the equilibration 
process. The MD simulation then used a cutoff of 12 Å for non-bonded interactions and 
weak-coupling algorithm (100) was used to maintain a 300 K constant temperature. A total of 10 
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ns of MD simulation was performed using a 2-fs time step in conjunction with the SHAKE 
algorithm (101) to constrain bond length between hydrogen and heavy atoms in the system. All the 
simulations were conducted on the Mississippi Center for Supercomputing Research‟s Altix 
cluster computer. 
Analysis of the MD data was done on a dual-core Mac desktop. First, the total energy of the 
10-ns MD simulation was plotted with respect to time to determine the regime within which the 
MD reflects statistical equilibrium fluctuations around the energy minimum. Then the ptraj 
program from AMBER was used to calculate the root mean-square fluctuation (RMSF) of 4 
residues: active site Ser189, Glu310, His399 and "side door" Leu362, with respect to their starting 
coordinates. 
An in-house python program using the molecular modeling toolkit (MMTK) module 
(102), was used to analyze the MD simulation trajectory. The analysis was performed with a 
procedure modified from the work of McCammon and colleagues (103). As active site Ser189 and 
His399 are the two residues proposed to make initial contact with the ester bond to be cleaved 
(Figure 3-7) (66), the molecular surface of pnbCE was calculated at each step of the dynamics 
using a probe radius that was incremented by 0.1 Å until active site Ser189 and/or His399 no 
longer contribution to the molecular surface. The largest probe radius that could contact both 
residues was considered to provide the diameter of the active site gorge. The gorge diameter is 
plotted with respect to time in Figure 3-6b. 
The distances between 3 loop residues on Coil_5 and 6 active site gorge residues are 
measured using the ptraj program. For each of the 18 distance vectors, one data point is recorded 
every 0.1 ps and a total of 100,000 points are recorded during the 10-ns MD simulation. By using 
equation (1) and a similar cross-correlation analysis Equation 3-2,  
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the correlation coefficient Crρ is calculated for between distance vector pairs (Equation 
3-1) and between distance vector and gorge diameter (Equation 3-2). Here r and ρ are the distance 
vector and gorge diameter, respectively and the brackets indicate an average over the trajectory. 
The calculated Crρ is shown in Table 3-1 & 3-2. In Table 3-1, the 7 attributes are gorge diameter 
and the distances between Glu74 and 6 active site gorge residues (Tyr109, Met193, Ile270, 
Glu310, Leu362 and His399). The result was loaded into three 7 x 7 matrixes (one matrix for each 
of the three loop residues - Asp66, Leu68 and Glu74) and the value of Cij ranged from –1 (fully 
anti-correlated, the distance between the loop residue and active site gorge residue decreases while 
gorge diameter increases) to 1 (fully correlated, the distance between the loop residue and active 
site gorge residue increases while gorge diameter increases). The result of the matrix involving 
Glu74 is shown in Table 3-1. When combining the first rows of all three matrixes, which are the 
correlations between distance vectors and the gorge diameter, Table 3-2 is a direct measurement of 
the correlation between loop residue motions and gorge size.  
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CHAPTER 4 MAMMALIAN CARBOXYLESTERASES & 
ENZYME KINETICS OF PNBCE 
 
4.1 ABSTRACT 
Carboxylesterases (CEs) are ubiquitous enzymes that metabolize, among other compounds, 
the anticancer agent CPT-11. In this report, we used a bacterial enzyme, pnbCE as a model, to 
study the potential role of different structural components on enzyme metabolism. We identified 
two flexible loops, coil_5 and coil_21, in pnbCE using MD simulation and normal mode analysis. 
These loop regions are found to be highly variable among members of the / hydrolases fold 
superfamily. We generated loop-deleted mutants to assess the effects of such mutations on 
catalysis. Our results indicate that the removal of either one of the two surface loops (coil_5 and 
coil_21) dramatically reduces the kcat of the reaction. This effect suggests the two loops potentially 
act like a „lid‟ that protects the active site gorge by preventing substrates from diffusing out of the 
active site gorge. Additionally, we performed normal mode analysis on mammalian CEs and the 
results suggest their global motions are localized in the -helices between D and E of the 
catalytic domain. The constraint of the hinge regions between these -helices may explain the 
effect of previous mutation study on the side door residue Leu362. Overall, we propose that these 
highly flexible loops regions play an important role in catalysis by regulating the access of water or 
substrate to the active site. 
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4.2 INTRODUCTION 
Mammalian Carboxylesterases (CEs; EC 3.1.1.1) are a family of ubiquitous proteins that 
can be found in the endoplasmic reticulum (ER) and cytosol of many tissues in mammals. CEs 
cleave carboxylic esters into the corresponding alcohol and carboxylic acid. These enzymes are 
capable of catalyzing the hydrolysis of ester- and amide-containing substrates with a variety of 
chemical structures, including the activation of prodrugs such as anti-cancer drug CPT-11 and 
capecitabine (3) (104). They may also be involved in metabolizing illicit street drugs such as 
heroin and cocaine (105). CEs can also hydrolyze compounds such as short- and long-chain 
acyl-glycerols, long-chain acyl-CoA esters, and long-chain acylcarnitine. Carboxylesterases are 
responsible for the detoxification of xenobiotics across various species.  
Although the amino acid sequences of many CEs have been established using molecular 
cloning methods, according to the Ester database 
(http://bioweb.ensam.inra.fr/ESTHER/general?what=index), currently only 20 out 1394 CE 
sequences have crystal structures. Furthermore, these 20 structures are from 4 CE isozymes: 
human liver CE (hCE1), rabbit CE (rCE) and two bacterial CE (pnbCE and Est55). The remaining 
structures are either from different mutants or the same enzyme being crystallized with different 
inhibitors.  
CEs are important in activating anti-cancer prodrug CPT-11. Both hCE1 and hiCE are 
known to convert CPT-11 into its active form, SN-38, a topoisomerase I inhibitor. However, hiCE 
in the small intestine is much more efficient at converting CPT-11 than hCE1 (14). Thus, the 
overproduction of SN-38 in the small intestine causes tissue damage to this organ and contributes 
to the delayed diarrhea in patients, a side-effect that often requires hospitalization (14, 21).  
We are specifically interested in development of selective inhibitors of a CE isozyme, 
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human intestine CE (hiCE), with the purpose of reducing or eliminating the CPT-11 activation in 
the small intestine (25). Since the crystal structure of hiCE is not available, we developed a 
homology model of hiCE and compared the dynamic features of four CE isozymes, hCE1, hiCE 
(homology model), rCE and pnbCE, as well as using site-specific mutation of pnbCE as a model 
system in an attempt to identify the structural features responsible for substrate specificity. 
Despite being a bacterial model, as shown in Figure 4-1 and 4-2, pnbCE exhibits close 
sequence conservation and structural homology with mammalian CEs (12). The pnbCE has 
comparable activities with rabbit CE, which has the highest CPT-11 conversion rate among 
mammalian CEs toward the hydrolysis of o-NPA and CPT-11. Both enzymes showed reduced 
catalytic activities when corresponding amino acid residues were mutated (12). Since pnbCE is a 
bacterial model, it can be easily modified, expressed and purified in E. coli expression systems. 
Therefore, pnbCE makes an excellent model system for studying the structure-function 
relationship of human CEs. The information obtained from this study could ultimately be applied 
to the development of specific inhibitors of hiCE.  
 
4.3 RESULTS 
4.3.1 PROTEIN STRUCTURE MODELS 
A total of 3 crystal structures, hCE1 (pdb: 1MX5) (9), rCE (1K4Y) (13) and pnbCE (1QE3) (10), 
were used in this study. The missing loops, residues 66-74 and 414-420 of pnbCE, and residues 
355-370 and 450-466 of rCE, were inserted using Modeller (106). The structures of the deletion 
and insertion pnbCE mutants were modeled using Modeller as well. The final models of pnbCE 
mutants were evaluated with various tools including PROCHECK (107), VERIFY3D (108) and 
ERRAT2 (109) analysis. The overall quality factor of the wt- (1QE3), [coil_5]del- and  
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Figure 4-1. The alignment of x-ray crystal structures of pnbCE (PDB code: 1QE3) and 
hCE1 (1MX5) 
Blue cartoon representation structure is pnbCE and yellow structure is hCE1. They both belong to 
the / fold hydrolases superfamily. 
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The alignment of the relevant CEs are given below. 
rCE  MWLCALALASLAACTA---------WGHPSAPPVVDTVHGKVLGKFVSLEGFAQPVAVFL 51 
hCE1   MWLRAFILATLSASAA---------WGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFL 51 
hiCE   MRLHRLR-ARLSAVACGLLLLLVRGQGQDSASPIRTTHTGQVLGSLVHVKGANAGVQTFL 59 
pnbCE  M-----------------------------THQIVTTQYGKVKG------TTENGVHKWK 25 
                                    :  :  *  *:* *           *  :  
 
rCE    GVPFAKPPLGSLRFAPPQPAESWSHVKNTTSYPPMCSQDAVSGHMLSELFTNRKENIPLK 111 
hCE1   GIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLK 111 
hiCE   GIPFAKPPLGPLRFAPPEPPESWSGVRDGTTHPAMCLQDLTA--VESEFLSQFNMTFPSD 117 
pnbCE  GIPYAKPPVGQWRFKAPEPPEVWEDVLDATAYGPICPQ-------PSDLLSLSYTELPRQ 78 
       *:*:****:*  ** .*:*.* *. * : *:: .:* *        *::::     :* . 
 
rCE    -FSEDCLYLNIYTPADLTKRGRLPVMVWIHGGGLMVGGAS--TYDGLALSAHENVVVVTI 168 
hCE1   -LSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAAS--TYDGLALAAHENVVVVTI 168 
hiCE   SMSEDCLYLSIYTPAHSHEGSNLPVMVWIHGGALVFGMAS--LYDGSMLAALENVVVVII 175 
pnbCE  --SEDCLYVNVFAPDTPSQ--NLPVMVWIHGGAFYLGAGSEPLYDGSKLAAQGEVIVVTL 134 
         ******:.:::*    :  .**********.: .* .*   ***  *:*  :*:** : 
 
rCE    QYRLGIWGFFSTG--DEHSRGNWGHLDQVAALRWVQDNIANFGGDPGSVTIFGESAGGQS 226 
hCE1   QYRLGIWGFFSTG--DEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGES 226 
hiCE   QYRLGVLGFFSTG--DKHATGNWGYLDQVAALRWVQQNIAHFGGNPDRVTIFGESAGGTS 233 
pnbCE  NYRLGPFGFLHLSSFDEAYSDNLGLLDQAAALKWVRENISAFGGDPDNVTVFGESAGGMS 194 
       :****  **:  .  *:   .* * ***.***:**::**: ***:*. **:******* * 
 
rCE    VSILLLSPLTKNLFHRAISESGVA--LLSSLFRKN-TKSLAEKIAIEAGCKTTTSAVMVH 283 
hCE1   VSVLVLSPLAKNLFHRAISESGVA--LTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVH 284 
hiCE   VSSLVVSPISQGLFHGAIMESGVA--LLPGLIASS-ADVISTVVANLSACDQVDSEALVG 290 
pnbCE  IAALLAMPAAKGLFQKAIMESGASRTMTKEQAASTAAAFLQVLGINESQLDRLHTVAAED 254 
       :: *:  * ::.**: ** ***.:  :      .  .  :       :  .   : .    
 
rCE    CLRQKTEEELMEVTLKMKFMALDLVGDPKENTAFLTTVIDGVLLPKAPAEILAEKKYNML 343 
hCE1   CLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTV 344 
hiCE   CLRGKSKEEILAINKPFKMIPG---------------VVDGVFLPRHPQELLASADFQPV 335 
pnbCE  LLKAADQLRIAEKENIFQLFFQP--------------ALDPKTLPEEPEKSIAEGAASGI 300 
        *:   : .:      ::::                 .:*   * . * :  *.     : 
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rCE    PYMVGINQQEFGWIIPMQMLGYPLSEGKLDQKTATELLWKSYPIVNVSKELTPVATEKYL 403 
hCE1   PYMVGINKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYL 404 
hiCE   PSIVGVNNNEFGWLIPKVMRIYDTQK-EMDREASQAALQKMLTLLMLPPTFGDLLREEYI 394 
pnbCE  PLLIGTTRDEG-------YLFFTPDSDVHSQETLDAALEY-----LLGKPLAEKAADLYP 348 
       * ::* ..:*           :  ..   .:::    *        :   :     : *  
 
rCE    GGTDDPVKKKDLFLDMLADLLFGVPSVNVARHHRDAGAPTYMYEYRYRPSFSSDMRPKTV 463 
hCE1   GGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTV 464 
hiCE   GDNGDPQTLQAQFQEMMADSMFVIPALQVAHFQCSR-APVYFYEFQHQPSWLKNIRPPHM 453 
pnbCE  -------RSLESQIHMMTDLLFWRPAVAYASAQSHY-APVWMYRFDWHP-----EKPPYN 395 
                     .:::* :*  *::  *  :    **.::*.:  :*      :*    
 
rCE    IGDHGDEIFSVLGAPFLK-----EGATEEEIKLSKMVMKYWANFARNGNPNGEGLPQWPA 518 
hCE1   IGDHGDELFSVFGAPFLK-----EGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPE 519 
hiCE   KADHGDELPFVFRSFFGGN---YIKFTEEEEQLSRKMMKYWANFARNGNPNGEGLPHWPL 510 
pnbCE  KAFHALELPFVFGNLDGLERMAKAEITDEVKQLSHTIQSAWITFAKTGNPSTEAVN-WPA 454 
        . *. *:  *:              ::*  :**: : . * .**:.***. *.:  **  
 
rCE    YDYKEGYLQIGATTQAAQKLKDKEVAFWTELWAKEAAR--PRETEHIEL 565 
hCE1   YNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAKKAVEK-PPQTEHIEL 567 
hiCE   FDQEEQYLQLNLQPAVGRALKAHRLQFWKKALPQKIQELEEPEERHTEL 559 
pnbCE  YHEET----------RETVILDSEITIENDPESEKRQKLFPSKGE---- 489 
           :. :               :   .: : ..  .::  .    : .     
 
Figure 4-2. The sequence alignment of rabbit CE, human liver CE, human intestine CE, and 
a bacterial CE 
Coil_5 of pnbCE and its corresponding loops in mammalian CEs are highlighted in yellow and 
Coil_21 of pnbCE and its corresponding loops in mammalian CEs are highlighted in green. 
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[coil_21]del- pnbCEs are shown in Table 4-1. ERRAT is a program for verifying protein 
structures. Relatively high and consistent scores between wt- and mutant CEs suggest that the 
modeled mutant structures are reliable and accurate presentation of their protein structures. The 
3D structures of these three mutants are almost identical with the wild-type enzyme, except for the 
mutated loop regions. Therefore, these models should be reliable representations of the mutant 
pnbCEs. 
 
Table 4-1. The overall quality factors from the ERRAT2 server for wt- and mutant pnbCEs 
The ERRAT2 score is a measurement of the accuracy of a protein structure. Our mutant CE 
structures have ERRAT2 scores that are fairly close to wt-pnbCE. It means these models are good 
representation of the mutant protein structures. 
 
Protein ERRAT2 score 
wt-pnbCE 89.978 
[coil_5]del-pnbCE 87.716 
[coil_21]del-pnbCE 87.827 
 
 
4.3.2 CONSERVATION STUDY OF PNBCE 
The conservation study is done using the ConSurf server (110). The input sequence is the 
crystal structure of pnbCE (PDB: 1QE3). A sequence similarity search returns with 492 hits, 
including 350 unique protein sequences of known structure. These are the protein sequences 
similar to the pnbCE and they are probably also phylogenetically related to it. Finally, the 
conservation scores of every residue in pnbCE is calculated and colored with corresponding color. 
As shown in Figure 4-3, the warm color residues evolve slowly and are referred to as "conserved", 
while cold color residues evolve rapidly and are referred to as "variable". There are a few 
important results we can get from our conservation study. First of all, the  folding core of 
pnbCE, including the catalytic triad, is highly conserved. For example, among the catalytic triad,  
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Figure 4-3. The conservation pattern obtained from the crystal structure of pnbCE 
The 3-D structure of pnbCE is presented as a cartoon model, and colored according to the 
conservation scores. The color-coding bar shows the coloring scheme, with the warm color as 
conserved residues and cold color as variable residues. The catalytic domain of the enzyme, 
including the catalytic triad (Ser189, Glu310 and His399), is highly conserved while the regulatory 
domain of pnbCE is highly variable.  
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Ser189 and Glu310, each has only two variable residues among 350 sequences. His399 has no 
alternative residue and is the most conserved residue in the entire sequence. It is expected that the 
functional regions of the protein are highly conserved. That‟s the reason why these hydrolases are 
so diverse in sequence but be able to keep the same folding pattern and their common function – 
hydrolyze small organic molecules. Secondly, variability is just as important as conservation for 
reflecting protein functions. During the evolution of this particular enzyme, it adapts to chemical 
and biological envioronments in different organisms. In order for the same enzyme to perform 
slightly different tasks, such as selecting different substrates, it has to evolve residues around its 
functional regions to create this functional variability. One example is the surface loop regions, 
coil_5 and coil_21, as we talked about in the previous chapter, which is not just structurally 
flexible, but also highly variable in sequence. For instance, although coil_5 is missing in Figure 
4-3 (because it‟s missing in the crystal structure), each residue in this loop has a conservation score 
of 1 or 2 (on a 1 to 9 scale with 1 being most variable). These loops may not be directly involved in 
the hydrolysis mechanism, but help the enzyme select different substrates based on their dynamic 
motions. This is also part of our goal in this study: to find out the structural features that are varible 
among the  hydrolases fold superfamily, as well as the structural features that are conserved.  
Other highly variable regions in pnbCE structure are the -helix bundles that consist of the 
lower side of the active site gorge. They are also the main components of the regulatory domain of 
pnbCE. Their dynamic motions correspond to the motions from residue 310 to residue 360, which 
we observed and will discuss in detail in our normal mode analysis. Similar structural features can 
be seen from other members of the  hydrolases fold superfamily. For instance, as one of the 
smallest member of the superfamily, Fusarium solani cutinase (FsCUT) has only 214 amino acids 
(comparing with pnbCE‟s 489) (111). Although its catalytic domain is conserved, it lacks the 
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majority part of the regulatory domain. Its catalytic triad is protected by two short hydrophobic 
loops, the loops 80 to 88 and 180 to 188. Both loops show greater anisotropy than other residues in 
FsCUT and the motions of these loops produces a breath-like movement that plays an important 
role in its catalysis (111). It is highly likely that the regulatory domains of CEs adopt a similar role 
as the hydrophobic loops of FsCUT. Our hypothesis is that these helices in the regulatory domains 
of pnbCE isolate the active site of the enzyme from external solvent and possible incorporated in 
the reaction mechanism by regulating the entrance of water or substrate into the active site.  
 
4.3.3 NORMAL MODE ANALYSIS OF CES 
Normal mode analysis (NMA) is the simplest way to attain large-scale, low-frequency 
motions of molecular structures (81) (112) (113). A total of 6 normal mode calculations were 
carried out, including the wild-type pnbCE (wt-), 2 loop deletion mutants ([coil_5]del- and 
[coil_21]del-), and 2 pnbCE mutants with known crystal structure (1C7J and 1C7I (10)). The latter 
two structures can be found in protein databank (PDB), and they both have multiple mutations 
comparing with the wt-pnbCE (1C7J has 11 mutations and 1C7I has 7 mutations). Some of their 
mutations stabilized the two loop regions that were missing in the wild-type (10), so both these two 
mutants have complete crystal structures.  
The first five lowest-frequency vibrational normal modes for all wt- and mutant pnbCEs 
were generated by the ElNémo web server (55). Except for the [coil_21]del-pnbCE mutant, whose 
second lowest frequency mode (because the lowest frequency mode has a low collective value, 
which means this mode was localized in the termini) was used in analysis, all the other 5 
calculations used their lowest frequency mode (mode 7). The root-mean-square-deviation (RMSD) 
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of their low frequency modes are plotted in Figure 4-4. The gray bars represent the RMSD of 
wt-pnbCE and the RMSD of the mutants are colored according to the color legend.  
First of all, when we compare the wt-pnbCE with the two natural mutants (1C7J and 1C7I), 
it is not surprising that both loop regions (coil_5 and coil_21) have much lower RMSD values, just 
as their crystal structures suggested. On the other hand, it also verified the effectiveness of our 
wt-pnbCE structure. The wt-pnbCE has the two loops missing in its crystal structure and presented 
collective loop motions; while in contrast, the two mutants have stabilized loops in their crystal 
structures and were confirmed by the much constrained loop motions.  
The low frequency modes of all the mutants have very similar fluctuation profile, which is 
expected since our structural models for these mutants have almost identical backbones except for 
the loop regions. Unlike the two natural mutations, [coil_21]del-pnbCE  has a dominated loop 
motion around residues 66-76 similar to the wild-type, as its coil_5 is still intact. Similarly, the 
same motion as the wild-type was observed in the loop region 414-420 for the [coil_5]del-pnbCE. 
These two loop motions are structurally independent, which means deleting one loop doesn‟t 
affect the flexibility of the other loop.  
The other most significant motions other than the loops are the -helixes in residues 
220-270 and residues 310-360, and they correspond to the -helixes D1‟-D3‟ (D‟, the inserted 
-helixes in front of the D) and E1‟-E3‟ (E‟, the inserted -helixes in front of the E) of 
pnbCE in Figure 3-1, respectively. These -helixes are not part of the  folding core, but are 
inserted into D and E during evolution of the enzyme, as evident of being highly variable in 
Figure 4-4 (the -helixes located at the bottom of the structure). Interestingly, as part of the actual 
 folding core, D (residues 288-293) and E (residues 364-375) are located at the minima of 
the RMSD plot in Figure 4-4 and have extremely low flexibility compared with their neighboring  
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Figure 4-4. RMSD plots of the lowest-frequency normal mode of wt- and mutant pnbCEs 
Here wt-pnbCE is plotted in gray bars and mutants are colored according to the legend.  
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regions. They act as “hinge regions” that holds the mobile parts of the enzyme together. These 
residues are structurally important and usually high conserved among the whole family of enzyme.  
We also performed the same normal mode calculations on the mammalian CEs. Despite 
the fact their ability to convert large substrate, like CPT-11, differs dramatically, all 3 mammalian 
CEs exhibit almost identical low frequency normal modes. Although the loop motions are still 
there, they are not as dominant as the loops in the wt-pnbCE. Just like the natural pnbCE mutants, 
the dominated motions in these mammalian CEs are the -helix inserts. The signification of these 
motions will be discussed later in the discussion section.  
 
4.3.4 EXPRESSION AND PURIFICATION OF WILD-TYPE AND MUTANT PNBCES 
The pnbA gene was inserted into the pTriEx-3 vector to create the pTriEx-3/pnbA plasmid 
DNA. Although we only expressed our protein in E. coli cells, this pTriEx-3 vector has the 
advantage of providing high levels of protein expression in both mammalian cell lines and in 
bacteria. All the mutants are generated by using the site-directed mutagnesis protocol and their 
sequences are verified by DNA sequencing. After the expression, pnbCEs were purified by using 
Isoelectric fousing (IEF) method based on their Isoelectric points (pI value). The concentration of 
the wt- and mutant pnbCEs are determined by Bradford protein assay. The SDS-PAGE gel of the 
IEF purified pnbCEs are shown in Figure 4-5. The purifed enzymes are used in the following 
circular dichroism spectroscopy study and enzymatic kinetic study.  In Figure 4-6, it is shown the 
circular dichroism (CD) spectrums of the wild-type and mutant pnbCEs are similar, indicating the 
mutations didn‟t change the overall folding of pnbCEs. 
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Figure 4-5. SDS-PAGE gel of the IEF purified pnbCEs 
Approximately 10 μg of protein was loaded into each lane and following 
IEF purification, the gel was stained with Coomassie Blue. Lane 1 - protein standard; Lane 2 - 
After raw extraction; Lane 3 - After centrifuge and dialysis; Lane 4 - After IEF with ampholytes; 
Lane 5 - purified wt-pnbCE; Lane 6 - purified [coil_5]del-pnbCE; Lane 7 - purified 
[coil_21]del-pnbCE. 
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Figure 4-6. CD spectra of wt-, [coil_5]del- and [coil_21]del- pnbCEs 
 
 
 
 
 
 89 
 
 
Figure 4-7. Temperature denaturation of wt-, [coil_5]del- and [coil_21]del-pnbCEs.  
 
 
 90 
The melting temperature (Tm) of wt-pnbCE (Figure 4.7), 57.25 ºC, also matches to the 
literature value (114). The two mutants unfold at 51.04 ºC for [coil_5]del-pnbCE and 54.45 ºC for 
[coil_21]del-pnbCE.  
We calibrated a Superose 12 10/300 column using protein standards and applied a sample 
of the purified CE. It indicated that pnbCE had a predicted molecular weight of ~54kDa and 
pnbCE purifies as a monomer. 
 
4.3.5 ENZYME KINETICS OF WILD-TYPE AND MUTANT PNBCES 
The ortho-nitrophenyl acetate (o-NPA) is a common substrate for measurement of the 
esterase activity, because its hydrolysis product o-nitrophenyl (o-NP) is a yellow solution that 
absorbs at 420 nm. Kinetic parameters for o-NPA were determined by assessing the conversion of 
o-NPA to o-NP. All 3 enzymes were tested, including the wt-, [coil_5]del- and 
[coil_21]del-pnbCEs. As shown in Figure 4-8, all the enzymes exhibited standard 
Michaelis-Menten kinetics. As shown in Table 4-2, modest increases in the Km value were 
observed for the [coil_5]del- and [coil_21]del- mutant pnbCE compared to that of the wild-type 
pnbCE. The Vmax and kcat for the mutant CEs were 4.5-fold and 3-fold smaller than that for the 
wild-type enzyme, resulting in around 6-fold decrease in the catalytic efficiency of the 
loop-deleted mutant pnbCEs as compared to the wild-type enzyme. 
 
4.4 DISCUSSION 
Ultimately we are interested in the mechanism and efficiency of substrate hydrolysis, 
especially CPT-11, by mammalian CEs. The results presented in this study indicated that pnbCE 
can be used as a bacterial model for the analysis of specific mutations and their effects on drug 
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Table 4-2. Kinetic parameters of wt-, [coil_5]del- and [coil_21]del- pnbCE using o-NPA as a 
substrate 
 
protein 
Km 
(M) 
Vmax (mol·min
-1
· 
mg
-1
 protein)
 
kcat 
(s
-1
) 
kcat/Km 
(s
-1
mM
-1
) 
wt-pnbCE 1705  159 149.9  6.4 135.04 79.20 
[coil_5]del-pnbCE 2338  363 33.1  2.6 29.82 12.75 
[coil_21]del-pnbCE 3980  1784 52.1  14.1 46.94 11.79 
 
Km and Vmax values are presented as mean ± S.E. Previous studies used the extinction coefficient 
value of 13,600 M
-1
 cm
-1
 (2) (12) (115) for o-NP at 420 nm. When using this value, our Km and kcat 
parameters of wt-pnbCE agree with reference value. However, it is reported that 5,220 M
-1
 cm
-1
 is 
the more accurate extinction coefficient for o-NP (116) (117) and the kinetic parameters in Table 
4-2 are calculated using the new value.  
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Figure 4-8. Non-linear regression curve fitting of o-NPA hydrolysis by wt-, [coil_5]del- and 
[coil_21]del- pnbCEs 
 
 
 93 
catalysis. The roles of the surface dynamic loops gating the active site of different enzymes have 
been studied via various computational analyses (118) (119) (120). However, experimental 
evidence to support these proposed mechanisms are still very limited, especially for 
carboxylesterases.  
Based on our computational models, our hypothesis is that these loops act as a gate that 
protects the active site and substrate from external solvent. We created specific mutations on those 
two flexible loops of pnbCE in order to eliminate/constrain their dynamic motions. Our current 
study demonstrates that removing these loop motions from the enzyme dramatically influences the 
kinetic parameters of catalysis, including rates of substrate binding (Km) and chemical bond 
associating/breaking (kcat). As shown in Table 4-2, removing the loops reduced the rate of 
chemistry by around 4- fold. It clearly demonstrated the loops play an important role in the 
mechanism of hydrolysis. However, these two loops are located on the surface of the enzyme and 
they are away from the active site. Furthermore, our conservation study suggested that these loops 
are highly variable among members of the / hydrolases fold superfamily. Therefore, these loops 
were not expected to be directly involved in the catalysis (kcat). It was recently reported that 
substituting certain amino acids in the hCE1 loops near the entrance of its active site with the 
corresponding residues from rCE resulted in an hCE1 variant that has dramatically different 
kinetic parameters from the wild-type enzyme (121). So it is not uncommon for some surface loops 
to be involved in the catalysis step in this family of enzyme. However, the detailed mechanism that 
these loops incorporated in the reaction is still unclear.  
Since we demonstrated that the two loops (coil_5 and coil_21) have an open/close motion, 
one possible mechanism is that these two loops work together and act like a „lid‟ that cover the 
active site gorge. Once the substrate binds near the active site gorge, the lid closes up and prevents 
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the substrate from diffusing out of the active site. By removing part of the lid, this highly regulated 
process becomes “leaky” and substrate tends to diffuse in both directions, in and out of the active 
site. Therefore lower the overall Vmax of the catalysis. This „lid‟ mechanism would explain the 
significant decreases of kcat for the loop-deleted mutants comparing with wt-pnbCE. 
Furthermore, the existence of a “side door” or “back door” were suggested on the crystal 
structures of acetylcholinesterases (122) (17) and rabbit carboxylesterases (13). Previous studies 
have also shown that mutations of the side door residue Leu362 in pnbCE significantly reduce the 
hydrolysis rates of both o-NPA and CPT-11 (123) (16). We performed normal mode analysis on 
mammalian CEs and the results are shown in Figure 4-9. The flexible -helices in hCE1 are 
highlighted in Figure 4-9a and Figure 4-9b is the back view. The two blue residues are Val388 and 
Val424, which are the so-called “side door” residues in hCE1. They are located at the minimum 
RMSD value regions and likely act as hinge residues around the large -helical insertions between 
D and E. These hinges are previously reviewed and thought to be important in facilitating the 
large-scale, slower lid motions that produce a catalytically competent state (124). It was also 
previously suggested that the Phe363, which is adjacent to the side door residue Leu362 in pnbCE, 
act as a “hinge‟ residue between the -helices, which separate the regulatory and catalytic domains 
of CEs (15). As we demonstrated in our normal mode analysis (Figure 4-9c, d and e), these 
-helices are the most flexible components of mammalian CEs and these global motions are most 
likely also biologically important. By making mutations on Leu362 could potentially constrain the 
rotational ability of the hinge region and therefore constrains the collective motions of the 
-helices. Since previous experimental data suggested that the mutations at the side door residue 
Leu362 didn‟t affect the ionization of critical residues in the active site nor change the spatial 
orientation of the catalytic triad in the active site (125), our interpretation of the mutagenesis data  
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Figure 4-9. Normal mode analysis of mammalian CEs 
(a) The front view of lowest-frequency normal mode of human liver CE (hCE1). The red arrow 
indicates the motion of the residues in this mode. Yellow highlighted region is the helixes that are 
most flexible in this mode. (b) The back view of the same structure as (a). The two blue residues 
are Val388 and Val424. They are the so-called “side door” residues in hCE1, which are located at 
the hinge of two flexible helixes. (c, d, e) The RMSD plots of the lowest-frequency modes for 
hCE1, hiCE and rCE, respectively.  
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on the side door residues Leu362 offers an alternative reason that could contributes to the effect of 
side door mutations on hydrolysis.   
Overall we tested our hypothesis about the potential role of the two large surface loops in 
hydrolysis by making loop-deleted mutants and measuring their kinetic parameters. The mutants 
have shown significantly different kinetic parameters. Our results suggested that the loops are 
incorporated in the catalysis, possibly by preventing the substrate from diffusing out of the active 
site gorge. Our study also indicates that pnb CE is a valuable model for studying hydrolysis by 
mammalian CEs. Further experiments can be designed to test if this proposed mechanism about 
the loops is sequence-dependent. This can be done by swapping the loop sequences of pnbCE with 
the mammalian CEs. The result of this kinetic study should give us more insights about the role of 
these surface loops.  
 
4.5 MATERIALS & METHODS 
4.5.1 PROTEIN SEQUENCE CONSERVATION STUDY  
The conservation study is done by using the ConSurf server (110). It is a useful tool that 
enables the identification of biologically important regions of a protein, of known crystal structure, 
based on its close sequence homologues.  
The crystal structure of pnbCE (PDB: 1QE3) was used as the input file. The ConSurf 
server extracts the protein sequence information from the SEQRES record of the crystal structure 
or the ATOM record of other PDB file. Then it carries out a search for close homologous 
sequences using PSI-BLAST (126) in the UniProt database. The search uses the maximum and 
minimum sequence identity cutoffs set up by the user. It then performs the multiple sequence 
alignment (MSA) using the default MUSCLE (127) algorithm. The conservation score is 
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calculated using an empirical Bayesian method (128) based on the multiple sequence alignment 
result. Optionally, a phylogenetic tree can be built with the MSA result as well. Finally, the protein, 
with the conservation scores color-coded onto its surface, can be visualized using the Pymol (129) 
molecular visualization software. Some of the parameters used in the conservation study of pnbCE 
are listed in Table 4-3. To be noticed is that the max and min sequence identity cutoff used in this 
study is from 10% to 95% and it returns with 492 hits, including 350 unique protein sequences of 
known structure. Considering the total number of known crystal structures in the / hydrolases 
fold superfamily is a little over 900 sequences; this conservation study has a reliable sample pool 
that contains most of the phylogenetically related protein sequences. 
 
Table 4-3. Parameters used in the conservation analysis of pnbCE 
  
ConSurf parameter name Parameter value 
Protein pnbCE 
PDB code 1QE3 
Multiple Sequence Alignment algorithm MAFFT 
Protein Database UniProt 
Method to calculate conservation scores Bayesian 
Model of substitution for proteins JTT 
Max %ID between sequences 95 
Min %ID between sequences 10 
PSI-BLAST hits 492 
Unique sequences 350 
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4.5.2 NORMAL MODE ANALYSIS 
Normal mode analysis (NMA) was performed on the ElNémo web server (55), which is a 
web interface to the Elastic Network Model that implements the „rotation-translation-block‟ 
(RTB) approximation. The starting structures were described previously in section 4.3.1. The 
number of residues that are treated as a rigid body value (NRBL) was determined by the server as 
a function of protein size to optimize computation speed. A cutoff of 8 Å was used to identify 
elastic interactions. We are interested the 5 lowest non-zero frequency modes (modes 7-11) that 
were generated. The output of NMA is a series of trajectory files in Protein Data Bank (PDB) 
format, which include 11 structures by default: the original input structure and ten frames 
representing the motions between the two conformational extrema of the normal mode. 
Some of the normal modes have a low degree-of-collectivity value less than 0.2, which 
meant only a few atoms within the N- or C-termini of the structure were involved in these motions. 
For the purpose of analyzing structural and functional relationship, these modes were ignored due 
to the lack of global conformational significance. The lowest-frequency non-localized mode for 
each enzyme was used for further analysis. A total of 9 normal mode analyses were performed in 
this study. 
 
4.5.3 BACTERIAL STRAINS AND VECTORS 
Host bacterial strain for plasmid preparation, XL-10 gold supercompetent cells, were 
purchased from Stratagene. The E. coli expression host strain, Origami B(DE3)pLacI and the 
expression vector pTriEx-3, was obtained from Novagen.  
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4.5.4 PNBA GENE ISOLATION 
The pnbA gene encoding pnbCE was isolated from B. subtilis genomic DNA using PCR as 
described earlier (12). The pnbA coding sequence was inserted into the BamHI restriction site of 
pTriEx-3 vector, to create the pTriEx-3/pnbA plasmid DNA.  
 
4.5.5 MUTAGENESIS 
In general, all the mutations were generated by using the Phusion site-directed mutagenesis 
kit from Finnzymes. Using pTriEx-3/pnbA plasmid as a template, the [coil_5]-del pnbCE mutant 
was made by PCR using primer pair: 5‟-(phosphate) CGCCAGTCCGAGGATTGCTTG -3‟ and 
5‟-(phosphate) AGACGGCTGCGGGCAAATAGAG. The [coil_21]-del pnbCE mutant was 
made using primer pair: 5'-(phosphate) ATTACGGATG AGGTGAAACA GCTTTCTC -3' and 
5'-(phosphate) CAATCCGTCC AGATTTCCAA AGAC -3'. Linear PCR products were purified 
using QIAquick PCR purification kit (QIAGEN), and were ligated back into circular plasmid 
DNA. After transformed to XL-10 Gold supercompetent cells, both deletion mutants plasmid were 
purified using QIAfilter plasmid purification kit (QIAGEN). All three deletion mutants were 
confirmed by DNA sequencing (protein and DNA sequences are shown in Appendix A4 and A5, 
respectively). 
 
4.5.6 PROTEIN EXPRESSION AND PURIFICATION 
All 3 deletion mutants, along with wt-pnb plasmids were transformed into E. coli 
expression strain, Origami B cells. After 24 hours, a 5 mL overnight SOC medium containing the 
appropriate concentrations of antibiotics was grown from a single colony for each mutant and wild 
type. On the second day, the 5 mL overnight bacterial culture was transferred to 2x 500 mL SOC 
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medium with antibiotics. After 3~4 hours of cell growth, protein expression was induced with 
1mM IPTG. Another 3~4 hours following induction, cells were harvested with centrifugation. 
Protein was extraced using 30 mL of Bug-Buster reagent (Novagen). Protein extracts were 
dialyzed against 10 mM HEPES buffer (pH 7.4) overnight before preceding to isoelectric focusing. 
wt-pnb and [coil_21]-del pnbCE mutant CEs were mixed with Bio-Lyte 3/5 ampholytes (Bio-Rad), 
while [coil_5]-del pnbCE mutant was mixed with Bio-Lyte 5/7 ampholytes. After 4~5 hours of 
focusing, 20 protein fractions were collected. CE activity was tested and the fractions with high 
levels of CE activity were pooled. Salt concentration was adjusted to 1 M using 4 M NaCl. The 
ampholytes were removed by overnight dialysis in 10 mM Hepes (pH 7.4) with 50 mM NaCl. 
Purity of the CEs were determined by SDS-PAGE gels (Figure 4-5). The molecular weight of each 
protein was determined by applying a protein sample to a calibrated Superose 12 10/300 
chromatography column (GE Healthcare). Protein concentrations were determined by standard 
Bradford protein assay.  
 
4.5.7 CE ASSAY 
A spectrophotometric assay was used in determining CE activities. Generally, a constant 
amount of enzyme was incubated with 3 mM of o-NPA, as the substrate, in 50 mM HEPES buffer 
(pH 7.4). The changes in absorption per minute were measured spctrophotometrically at 420 nM 
using a Cary-4 UV-VIS spectrophotometer. The CE activities were expressed as micromoles of 
o-NP produced per minute per milligram of CE. 
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4.5.8 CIRCULAR DICHROISM SPECTROSCOPY 
 CD spectra for all three enzymes were acquired on a Model 202SF CD Spectrometer (Aviv) 
from 200 to 300 nm, with a 5 s averaging time in 5 mM sodium phosphate, 50 mM NaCl, pH 7.4. 
The measured delta absorbance is converted into the mean residue ellipticity unit 
(degrees·cm
2
·dmol
-1
·residue
-1
). 
 For the temperature-induced unfolding experiment, a 1-cm cuvette with a screw top was 
used to prevent evaporation of the solution at high temperatures. The temperature probe was 
inserted through the cuvette screw top to monitor temperature changes. Protein concentrations of 1 
μM in 5 mM sodium phosphate, 50 mM NaCl, pH 7.4, were used for denaturation experiment. The 
unfolding measurement was performed within a temperature range of 15–85°C. The temperature 
ramp was set at 1°C/min, with data taken every degree. The equilibration time at each temperature 
was 30 s. The acquisition time was 5 s. The measurements were taken at 222 nm. The melting 
temperature is calculated based on the curve fitting of the data points into the empirical unfolding 
equation, 
 (Equation 4-1) 
Where A is the  Absorbance from CD spectra, T is the temperature of the probe, Af and A0 are the 
final and initial temperature,  is the curve coefficient and Tm is the melting temperature of the 
protein sample.  
 
4.5.9 o-NPA KINETICS 
In general, kinetic parameters were determined by incubating different concentrations of 
o-NPA with constant amounts of CEs. o-NPA solutions were diluted into ranges from 16 mM to 
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0.25 mM in 50 mM HEPES buffer (pH 7.4) with a 16 mM o-NPA stock. The conversion of o-NPA 
to o-NP was monitored at 420 nm for 30 s. The reaction velocities were calculated from the data 
points and the kinetic parameters and r
2
 values are determined by using non-linear regression with 
Prism software (Graph Pad). 
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APPENDIX 
A.1 PERL SCRIPTS 
A.1.1 Gorge_file_process.pl  
*This script is used to generate the gorge fluctuation data in MD.* 
#!/usr/bin/perl -w 
open outFile, ">pnbCE_Gorge_10ns.dat"; 
@files = <*.dat>; 
foreach $file (@files) { 
  $file =~ /^\D+(\d+).dat$/; 
  $ns = $1 - 12; 
  open inFile, $file; 
  while (defined($line = <inFile>)) { 
   chomp $line; 
   $line =~ /^(\d+), (\S+)$/;  
   $time = $ns + 0.0001*$1; 
   $gorgeSize = 10*$2; 
   print outFile "$time\t$gorgeSize\n"; 
   } 
}  
close inFile; 
close outFile; 
 
A.1.2 gorge_correlation.pl 
*This is script is used in analyzing the vector and gorge diameter correlation data.* 
#!/usr/bin/perl -w 
open outFile_c, ">pnbCE_overall_correlation_2.dat"; 
print outFile_c "residue number\tcorrelation value\n"; 
@files = <*.rms>; 
foreach $file (@files) { 
 $file =~ /^\D+(\d+).rms$/; 
 $CA = $1; 
 open outFile_g, ">pnbCE_gorge_$CA.dat"; 
 print outFile_g "correlation calculation data between gorge diameter and RMSF of residue 
$CA\n\n"; 
 print outFile_g "time(ns)\tRMS(A)\tGorge Diameter\tGorgeDiaRMSF(A)\n"; 
 open RMS, $file; 
 $sumTop = $sumBottomRMS = $sumBotGorgeDiaRMSF = 0; 
 open GorgeDia, "pnbCE_gorge_diameter.dat"; 
 while (defined($lineRMS = <RMS>)) { 
 114 
  chomp $lineRMS;    
    $lineRMS =~ /^\s*([0-9]*\.?[0-9]*)\s+([0-9]*\.?[0-9]*)$/; 
    $RMS = $2; 
    $lineDia = <GorgeDia>;  
    chomp $lineDia; 
    $lineDia =~ /^\s*([0-9]*\.?[0-9]*)\s+([0-9]*\.?[0-9]*)$/;  
    $time = $1; 
    $gorgeDia = 2*$2; 
    $gorgeDiaRMSF = sqrt(($gorgeDia - 4.0522) * ($gorgeDia - 4.0522)); 
    $sumTop = ($RMS * $gorgeDiaRMSF) + $sumTop; 
    $sumBotRMS = ($RMS * $RMS) + $sumBottomRMS; 
    $sumBotGorgeDiaRMSF = ($gorgeDiaRMSF * $gorgeDiaRMSF) + 
$sumBotGorgeDiaRMSF; 
    print outFile_g "$time\t$RMS\t$gorgeDia\t$gorgeDiaRMSF\n"; 
   } 
   $aveTop = $sumTop / 100000; 
   $aveBotRMS = $sumBotRMS / 100000; 
   $aveBotGorgeDiaRMSF = $sumBotGorgeDiaRMSF / 100000; 
   $aveBottom = sqrt($aveBotRMS * $aveBotGorgeDiaRMSF); 
   $correlation = $aveTop / $aveBottom; 
   print outFile_c "$CA\t$correlation\n"; 
   close RMS; 
   close outFile_g; 
   close GorgeDia; 
}  
close outFile_c; 
 
A.1.3 gorge_correlation.pl 
*This is script is used to generating RMSD data.* 
open outFile, ">>deviations_from_ave.ptraj"; 
$count = 1; 
while ($count <= 489) { 
 print outFile "rms reference out pnbCE_dev_$count.rms time 0.1 :$count\n"; 
 $count ++; 
} 
close outFile; 
 
A.1.4 NMA_RMSD_process.pl 
*This is a perl script that processes the .rmsmod files got from normal mode analysis (elnemo 
server).* 
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$pi = 3.14159; 
@files = <*.rmsmod>; 
foreach $file (@files) { 
 open inFile, $file; 
 open outFile, ">$file.RMSD"; 
 while (defined($line = <inFile>)) { 
  chomp $line; 
  @fields = split (/\s+/, $line); 
  if ($fields[4] eq "CA") { 
   $RMSD = $fields[5] * 100; 
   $BF = ($RMSD * $RMSD) * 8/3 * $pi * $pi; 
   print outFile "$fields[3]\t$fields[2]\t$RMSD\t$BF\n"; 
  } 
 } 
 close inFile; 
 close outFile; 
} 
 
A.1.5 pnbCE_arrow.pl 
*This is a perl script that is used to process the pdb files from NMA. All the CA atom coordinates 
are passed into a VMD tcl file.* 
@files = <pnbCE_mode7.pdb>; 
foreach $file (@files) { 
 open inFile, $file; 
 open model_1, ">$file.m1"; 
 open model_11, ">$file.m11"; 
 
 while (defined($line = <inFile>)) { 
  chomp $line; 
  @fields = split (/\s+/, $line); 
  if ($fields[0] eq "MODEL" and $fields[1] == "1") {   
    $line = <inFile>; 
    $line = <inFile>; 
    chomp $line; 
    @fields = split (/\s+/, $line); 
    while ($fields[0] eq "ATOM") { 
     if ($fields[2] eq "CA") { 
      print model_1 
"$fields[5]\t$fields[3]\t$fields[6]\t$fields[7]\t$fields[8]\n"; 
     } 
     $line = <inFile>; 
     chomp $line; 
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     @fields = split (/\s+/, $line); 
    }  
  }  
  elsif ($fields[0] eq "MODEL" and $fields[1] == "11") { 
    $line = <inFile>; 
    $line = <inFile>; 
    chomp $line; 
    @fields = split (/\s+/, $line); 
    while ($fields[0] eq "ATOM") { 
     if ($fields[2] eq "CA") { 
      print model_11 
"$fields[5]\t$fields[3]\t$fields[6]\t$fields[7]\t$fields[8]\n"; 
     } 
     $line = <inFile>; 
     chomp $line; 
     @fields = split (/\s+/, $line); 
    }  
  }  
 } 
  
 close model_1; 
 close model_11; 
 close inFile; 
 
 open outFile, ">$file.tcl"; 
 print outFile <<'VMD1'; 
# copy and paste the content of this file into VMD tcl console 
 
display resize 1000 1000 
draw color red 
 
proc vmd_draw_arrow {mol start end {res 28}} { 
 set middle [vecadd $start [vecscale 0.9 [vecsub $end $start]]] 
 graphics $mol cylinder $start $middle radius 0.15 resolution $res filled yes 
 graphics $mol cone $middle $end radius 0.35 resolution $res } 
 
proc vmd_draw_delete {args} { 
    set i 0 
    foreach list $args { 
        if {$i == 0} { 
     lassign $list mol 
            incr i 
        } 
        if {$list == "all"} { 
            graphics $mol delete all 
     return 
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        } 
        foreach id $list { 
            graphics $mol delete $id 
        } 
    } 
    return 
} 
 
VMD1 
 open arrow_start, "$file.m1"; 
 open arrow_end, "$file.m11"; 
 while (defined($line_1 = <arrow_start>)) { 
  chomp $line_1; 
  @f_start = split (/\s+/, $line_1); 
  $line_2 = <arrow_end>; 
  chomp $line_2; 
  @f_end = split (/\s+/, $line_2); 
  print outFile "draw arrow {$f_start[2] $f_start[3] $f_start[4]} {$f_end[2] 
$f_end[3] $f_end[4]}\n"; 
 } 
 close arrow_start; 
 close arrow_end; 
 close outFile; 
 
} 
 
A.1.6 NMA_RMSD_process.pl 
*This is a perl script used to process the .poc files (pocket information) and extract the pocket of 
interest. Then save as a pdb file.* 
open outFile, ">pnbCE_mode11_poc.pdb"; 
$match = "80"; 
@files = <*.poc>; 
@fields = []; 
foreach $file (@files) { 
 open inFile, $file; 
 $line = <inFile>; 
 while (defined($line = <inFile>)) { 
  chomp $line; 
  @fields = split (/\s+/, $line); 
  if ($fields[11] eq $match) { 
   print outFile "$line\n"; } 
 } 
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 close inFile; 
 close outFile; 
} 
 
 
A.2 PYTHON SCRIPTS 
A.2.1 NMA_RMSD_process.pl 
*This is a python script used to write a VMD script to draw arrows for NMA.* 
import string 
script_writer = open('VMD_arrow_model_1to2.tcl', 'w') 
 
file_start = open('model_1.bgf', 'r') 
script_writer.write("draw color blue\n") 
script_writer.write("proc vmd_draw_arrow {mol start end} {\n" 
                    "set middle [vecadd $start [vecscale 0.9 [vecsub $end $start]]]\n" 
                    "graphics $mol cylinder $start $middle radius 0.15\n" 
                    "graphics $mol cone $middle $end radius 0.35 }\n") 
 
for line_end in open('model_2.bgf', 'r'): 
  list_2 = string.split(line_end) 
  line_start = file_start.readline() 
  list_1 = string.split(line_start) 
                if list_1[0] == 'ATOM' and list_1[1] == list_2[1] : 
                        x = "draw arrow {%f %f %f} {%f %f %f}\n" %(float(list_1[6]), 
                                                                                   float(list_1[7]), 
                                                                                   float(list_1[8]), 
                                                                                   float(list_2[6]), 
                                                                                   float(list_2[7]), 
                                                                                   float(list_2[8])) 
                        script_writer.write(x) 
script_writer.close() 
 
A.2.2 pnbCE_Gorge_Analysis.py 
*This is a python script used to monitor the diameter of the gorge during MD simulation.* 
import string  
from math import * 
from MMTK import * 
from MMTK.PDB import PDBConfiguration 
from Numeric import * 
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from MMTK.MolecularSurface import * 
def set_atom_positions(): 
 offset = 0 
 for atoms in universe.atomList(): 
  atoms.setPosition(coords[offset: offset+3]) 
  offset = offset + 3 
  print atoms.position(None) 
   
# First, read the PDB file with the initial coordinates 
configuration = PDBConfiguration('test_2.pdb') 
universe = InfiniteUniverse() 
myprotein = configuration.createAll(None, 1) 
universe.addObject(myprotein) 
#universe.addObject(configuration.createAll(None, 1)) 
#print universe.objectList() 
 
#Determine the number of atoms 
no_atoms = len(universe.atomList()) 
 
# create a list with the gorge sizes to measure 
gorgeList = [] 
for i in range(0,11): 
 for j in range(0,10): 
  gorgeList.append(0.1*float(i)+0.01*float(j)) 
gorgeList.sort() 
 
#change the Van der Waal's radii to those used by SPOCK 
vdw = {'H': 0.11, 'C':0.155,'N':0.14,'O':0.135,'S':0.181} 
for atom in universe.atomList(): 
 atom.vdW_radius = vdw[atom.symbol] 
 
# Open the Amber mdcrd file  
#coords =[] 
input = open('2QE3_2.md.x','r') 
# Skip the first line: it's just a title 
input.readline() 
 
# set the number of frames to read 
no_frames = 1 
for j in range(no_frames): 
 coords = []  
 while len(coords) < no_atoms*3: 
  inputline = string.split(input.readline()) 
   
  for i in range(len(inputline)): 
   coords.append(string.atof(inputline[i])/10.0) 
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 # Skip the box line 
 #input.readline() 
 set_atom_positions() 
  
 maxGorgeSize = 0.0 
 for gorgeSize in gorgeList: 
  total_area = 0.0 
  #print "frame %s, size %s" %(i,gorgeSize) 
  #pr = float(gorgeSize) + 0.0 
  his399 = ser189 = 0 
  protsurf = surfaceAtoms(myprotein, probe_radius = gorgeSize) 
  for mykey in protsurf.keys(): 
   key_string = "%s" % mykey 
   if string.find(key_string,'His399') >= 0: 
    his399 = 1 
   elif string.find(key_string,'Ser189') >= 0: 
    ser189 = 1 
    #print key_string + " , " + "%s" % protsurf[mykey] 
    #total_area = total_area + protsurf[mykey] 
  mystring = "%s %s" % (ser189,his399)  
  print "gorge: %s, residues found:" % gorgeSize, 
  print mystring 
  if ser189 and his399: 
   maxGorgeSize = gorgeSize 
  else: break 
 
  #print pr,total_area 
 print "frame %s, max %s" % (j,maxGorgeSize) 
# outList.append("%s, %s\n" % (i+1, maxGorgeSize)) 
#outFile = open('race_gorge_long.dat','w') 
#outFile.writelines(outList) 
#outFile.close() 
input.close() 
 
A.2.3 GetAveCoords.py 
*This is a python script used for making a cross-correlation matrix for the C-alpha carbons during 
a dynamics run.* 
import string  
from math import * 
from MMTK import * 
from MMTK.PDB import PDBConfiguration, PDBOutputFile 
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from Numeric import * 
#from MMTK.MolecularSurfaceNSC import * 
from MMTK import MolecularSurface, MolecularSurfaceNSC 
from MMTK.Proteins import Protein 
from Scientific.Geometry import * 
 
import os 
#import math 
import sys 
#thishostnum = int(sys.argv[1]) 
#numHosts = 23.0 
#numFrames = 10000.0 
#frameSections = numFrames / numHosts 
#myFramesStart = int((thishostnum-1)*frameSections + 0.5) +1 
myFramesStart = 1 
#myFramesEnd = myFramesStart + 200 
myFramesEnd = 10 
#int(thishostnum*frameSections + 0.5) 
 
#print "node %i, frameStart %i, frameEnd %i" % ( thishostnum, myFramesStart, myFramesEnd ) 
 
def set_atom_positions(atoms_List): 
 offset = 0 
 for atoms in atoms_List : 
  atoms.setPosition(Vector(coords[offset], coords[offset+1], coords[offset+2])) 
  offset = offset + 3 
 
# First, read the PDB file with the initial coordinates 
#configuration = PDBConfiguration('2QE3_2_mdstart.pdb') 
universe = InfiniteUniverse() 
universe.protein = Protein('2QE3_2_mdstart.pdb') 
#myprotein = configuration.createAll(None, 1) 
myprotein = universe.protein 
#universe.addObject(myprotein) 
# this next statement is to force MMTK to assign indices to all atoms 
universe.configuration() 
#universe.protein = Protein(myprotein) 
 
# create a list of the atoms in PDB order 
natoms = universe.numberOfAtoms() 
atoms = natoms*[None] 
for atom in universe.atomList():  
 atoms[atom.index] = atom 
 #aindex = "%s" % atom.index 
 #print atom, string.atoi(aindex) 
 #print atom.name 
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# now, the list "atoms" will be in the same order as the PDB file.  
# here's a list of the C_alpha from the PDB file 
CA_List = [] 
for a in atoms: 
 if a.name == 'C_alpha' : 
  CA_List.append(a) 
#Determine the number of atoms 
no_atoms = len(universe.atomList()) 
 
# Open the Amber mdcrd file  
input = open('2QE3_2.md.x','r') 
# Skip the first line: it's just a title 
input.readline() 
 
#Skip down to the start of the frame you want 
 
j = 1 
while j < myFramesStart: 
 coords = []  
 while len(coords) < no_atoms*3: 
  inputline = string.split(input.readline()) 
  for i in range(len(inputline)): 
   coords.append(string.atof(inputline[i])/10.0) 
 j=j+1 
 
# Set up the output  
#outFile = open('/home/analysis/2QE3_7.md.newdat'+str(thishostnum),'w') 
outFile = open('atom_CA_ave.pdb', 'w') 
ave_coords = [] 
for j in range(3*len(CA_List)): 
 ave_coords.append(0.0) 
# Start reading frames 
total_frames = float(myFramesEnd + 1 - myFramesStart) 
for j in range(myFramesStart, myFramesEnd+1): 
 coords = [] 
 while len(coords) < no_atoms*3: 
  inputline = string.split(input.readline()) 
   
  for i in range(len(inputline)): 
   coords.append(string.atof(inputline[i])/10.0) 
 # set the new atom positions from the coordinates 
 set_atom_positions(atoms) 
# outFile2 = PDBOutputFile("test%s.pdb" % j) 
# outFile2.write(universe.protein) 
# outFile2.close() 
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 # get the CA coords and average 
 index_coords = 0 
 for CA_atoms in CA_List : 
  xyz = CA_atoms.position() 
  ave_coords[index_coords] = ave_coords[index_coords] + (xyz.x()/total_frames) 
  ave_coords[index_coords+1] = ave_coords[index_coords+1] + 
(xyz.y()/total_frames) 
  ave_coords[index_coords+2] = ave_coords[index_coords+2] + 
(xyz.z()/total_frames) 
  index_coords = index_coords + 3 
  
name = 'ATOM' 
serial = 7524 
residue = 'UNK' 
res_no = 490 
atom_type = 'CA' 
index_coords = 0 
for CA_atoms in CA_List : 
 #xyz = CA_atoms.position() 
 outFile.write( "%-6s%5s  %-4s%-4s %4d    %8.3f%8.3f%8.3f\n" % 
(name,serial,atom_type,residue,res_no,ave_coords[index_coords]*10,ave_coords[index_coords+
1]*10,ave_coords[index_coords+2]*10) ) 
 index_coords = index_coords+3 
 serial = serial + 1 
  
#outString = "%s\t%s\n" % (j, maxGorgeSize) 
#outFile.write( outString ) 
# outFile.flush() 
# outList.append("%s, %s\n" % (i+1, maxGorgeSize)) 
#outFile.writelines(outList) 
outFile.close() 
input.close() 
 
A.2.4 crosscorrel5.py 
*This is a python script used for constructing DCCM during a dynamics run.* 
import string 
from math import * 
from MMTK import * 
from MMTK.PDB import PDBConfiguration, PDBOutputFile 
from Numeric import * 
from MMTK.Proteins import Protein 
from Scientific.Geometry import * 
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import os 
#import math 
import sys 
 
#thishostnum = int(sys.argv[1]) 
#numHosts = 23.0 
#numFrames = 10000.0 
#frameSections = numFrames / numHosts 
#myFramesStart = int((thishostnum-1)*frameSections + 0.5) +1 
myFramesStart = 1 
#myFramesEnd = myFramesStart + 200 
myFramesEnd = 10 
#int(thishostnum*frameSections + 0.5) 
#print "node %i, frameStart %i, frameEnd %i" % ( thishostnum, myFramesStart, myFramesEnd ) 
 
def set_atom_positions(atoms_List): 
 offset = 0 
 for atoms in atoms_List : 
  atoms.setPosition(Vector(coords[offset], coords[offset+1], coords[offset+2])) 
  offset = offset + 3 
 
def matrix_reloaded(ma, fname) : 
 # NOTE: the first line of every matrix file has to contain the number of frames used in 
averaging 
 matrix_file = open(fname,'r') 
 frames = float(matrix_file.readline()) 
 if len(ma.shape) == 1 : 
  for i in range(ma.shape[0]) : 
   ma[i] = float(matrix_file.readline()) 
 elif len(ma.shape) == 2 : 
  for i in range(ma.shape[0]) : 
   splitline = string.split(matrix_file.readline()) 
   for j in range(ma.shape[1]) : 
    ma[i,j] = float(splitline[j]) 
 else: 
  matrix_problem = "The matrix %s is not supported" % fname 
  raise matrix_problem 
 return frames 
   
def matrix_offloaded(ma, frames, fname) : 
 matrix_file = open(fname,'w') 
 matrix_file.write("%i\n" % frames) 
 if len(ma.shape) == 1 : 
  for i in range(ma.shape[0]) : 
   matrix_file.write("%f\n" % ma[i]) 
 elif len(ma.shape) == 2 : 
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  for i in range(ma.shape[0]) : 
   for j in range(ma.shape[1]) : 
    matrix_file.write("%f\t" % ma[i,j]) 
   matrix_file.write("\n")  
 else: 
  matrix_problem = "The matrix %s is not supported" % fname 
  raise matrix_problem 
 
# Set flags for reading or writing 
saveflag = 0 
readflag = 0 
for flag in sys.argv[1:] : 
 if flag == '-s' : saveflag = 1 
 elif flag == '-r' : readflag = 1 
 else :  
  raise "command line argument %s not recognized" % flag 
   
# First, read the PDB file with the initial coordinates 
#configuration = PDBConfiguration('2QE3_2_mdstart.pdb') 
universe = InfiniteUniverse() 
universe.protein = Protein('2QE3_2_mdstart.pdb') 
#myprotein = configuration.createAll(None, 1) 
myprotein = universe.protein 
#universe.addObject(myprotein) 
# this next statement is to force MMTK to assign indices to all atoms 
universe.configuration() 
#universe.protein = Protein(myprotein) 
 
# create a list of the atoms in PDB order 
natoms = universe.numberOfAtoms() 
atoms = natoms*[None] 
for atom in universe.atomList():  
 atoms[atom.index] = atom 
 
# now, the list "atoms" will be in the same order as the PDB file.  
# here's a list of the C_alpha from the PDB file 
CA_List = [] 
for a in atoms: 
 if a.name == 'C_alpha' : 
  CA_List.append(a) 
 
# Get the average CA coordinates from an external file 
CA_input = open('2QE3_atom_CA_ave.pdb','r') 
CA_ave_coords_V = [] 
for i in range(len(CA_List)): 
 CA_inputline = CA_input.readline() 
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 if not CA_inputline :  
  CA_input_Error = "something is wrong with the CA file!" 
  raise CA_input_Error 
 CA_splitline = string.split(CA_inputline) 
 r_ave = Vector(float(CA_splitline[5])/10.0, float(CA_splitline[6])/10.0, 
float(CA_splitline[7])/10.0) 
 CA_ave_coords_V.append(r_ave) 
 # Note that this should be the same order as the CA's in the PDB file 
  
#Determine the number of atoms 
no_atoms = len(universe.atomList()) 
 
# set up an array to hold the dynamic cross-correlation data 
# this uses the zeros() function from Numeric 
DCC_array = zeros((len(CA_List), len(CA_List)), Float) 
# and three arrays to hold the delta_r values for the CA_atoms  
delta_r = zeros((len(CA_List)), Float) 
delta_r2= zeros((len(CA_List)), Float) 
dri_drj= zeros((len(CA_List), len(CA_List)), Float) 
 
# What are the total number of frames to used? 
total_frames = float(myFramesEnd + 1 - myFramesStart) 
 
# See if you need to read in earlier matrices 
if readflag : 
 matrix_reloaded(dri_drj, 'dri_drj_matrix') 
 #old_frames = matrix_reloaded(delta_r, 'delta_r_matrix') 
 old_frames = matrix_reloaded(delta_r2, 'delta_r2_matrix') 
 total_frames = old_frames + total_frames 
 for i in range(len(CA_List)) : 
  #delta_r2[i] = delta_r2[i] + (delta_r[i]*delta_r[i])/total_frames 
  delta_r2[i] = delta_r2[i]*old_frames/total_frames 
  for j in range(len(CA_List)) : 
   dri_drj[i,j] = dri_drj[i,j]*old_frames/total_frames 
    
# Begin working with the amber coordinates file 
# Open the Amber mdcrd file  
input = open('2QE3_2.md.x','r') 
# Skip the first line: it's just a title 
input.readline() 
 
#Skip down to the start of the frame you want 
 
j = 1 
while j < myFramesStart: 
 coords = []  
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 while len(coords) < no_atoms*3: 
  inputline = string.split(input.readline()) 
  for i in range(len(inputline)): 
   coords.append(string.atof(inputline[i])/10.0) 
 j=j+1 
 
# Start reading frames 
#total_frames = float(myFramesEnd + 1 - myFramesStart) 
for j in range(myFramesStart, myFramesEnd+1): 
 coords = [] 
 while len(coords) < no_atoms*3: 
  inputline = string.split(input.readline()) 
   
  for i in range(len(inputline)): 
   coords.append(string.atof(inputline[i])/10.0) 
    
 # set the new atom positions from the coordinates 
  
 set_atom_positions(atoms) 
  
 # Calculate the delta_r and delta_r2 values for this frame    
 for i_coords in range(len(CA_List)) : 
  delta_r[i_coords] = (CA_List[i_coords].position() - 
CA_ave_coords_V[i_coords]).length() 
  delta_r2[i_coords] = delta_r2[i_coords] + 
(delta_r[i_coords]*delta_r[i_coords])/total_frames 
   
 # Calculate the dri_drj matrix   
 for i_coords in range(len(CA_List)) :  
  for j_coords in range(len(CA_List)) :    
   dri_drj[i_coords,j_coords] = dri_drj[i_coords,j_coords] + 
(delta_r[i_coords]*delta_r[j_coords])/total_frames    
    
# The loop over frames ends here 
input.close() 
 
# Now offload the matrices if needed.   
#  Note that you have to offload before taking the sqrt as you want the sqrt of the final sum 
if saveflag : 
 matrix_offloaded(dri_drj, total_frames, 'dri_drj_matrix') 
 #matrix_offloaded(delta_r, 'delta_r_matrix') 
 matrix_offloaded(delta_r2, total_frames, 'delta_r2_matrix') 
 
# Now take the square root of the delta_r2 matrix 
for i in range(len(CA_List)) : 
 delta_r2[i] = sqrt(delta_r2[i]) 
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# calculate the DCC matrix and write it out 
# Set up the output  
DCC_outFile = open('2QE3_2.md.DCC', 'w') 
for i in range(len(CA_List)) : 
 for j in range(len(CA_List)) : 
  DCC_array[i,j] = dri_drj[i,j]/(delta_r2[i]*delta_r2[j]) 
  DCC_outFile.write("%f\t" % DCC_array[i,j]) 
 DCC_outFile.write("\n") 
DCC_outFile.close() 
 
 
A.3 OTHER SCRIPTS 
A.3.1 runmd_3.in 
*This is an AMBER script used for production simulation.* 
  run MD at 300K 
 &cntrl 
 imin=0, 
 ntc=2, ntf=2, 
 cut=12.0, igb=1, saltcon=0.2, gbsa=1, 
 ntpr=50, ntwx=50, ntwe=50, 
 nstlim=500000, dt=0.002, 
 ntt=1, tempi=300.0, temp0=300.0, tautp=2.0, 
 ntx=5, irest=1, ntb=0, ntwr=500, 
        nscm=500, 
 &end 
 
A.3.2 pnbCE_RMSD_10ns.ptraj 
*This is an AMBERtool script used for analyzing the output trajectory files and generating the 
RMSD of the overall structure.* 
trajin 2QE3_12.md.am8.x 
trajin 2QE3_13.md.am8.x 
trajin 2QE3_14.md.am8.x 
trajin 2QE3_15.md.am8.x 
trajin 2QE3_16.md.am8.x 
trajin 2QE3_17.md.am8.x 
trajin 2QE3_18.md.am8.x 
trajin 2QE3_19.md.am8.x 
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trajin 2QE3_20.md.am8.x 
trajin 2QE3_21.md.am8.x 
reference 2QE3_2_mdstart.pdb 
rms reference out pnbCE_RMSD_10ns.rms @CA time 0.1 
 
A.3.3 pnbCE_RMSD_residue.ptraj 
*This is an AMBERtool script used for analyzing the output trajectory files and generating the 
RMSD of each residue in the protein structure.* 
trajin 2QE3_12.md.am8.x 
trajin 2QE3_13.md.am8.x 
trajin 2QE3_14.md.am8.x 
trajin 2QE3_15.md.am8.x 
trajin 2QE3_16.md.am8.x 
trajin 2QE3_17.md.am8.x 
trajin 2QE3_18.md.am8.x 
trajin 2QE3_19.md.am8.x 
trajin 2QE3_20.md.am8.x 
trajin 2QE3_21.md.am8.x 
reference 2QE3_2_mdstart.pdb 
rms reference out pnbCE_RMSD_12.rms @CA time 0.1 
atomicfluct out pnbCE_RMSD_residue.rms @CA byres 
atomicfluct out pnbCE_RMSD_residue.bfactor @CA byres bfactor 
 
A.3.4 active_site_fluc.ptraj 
*This is an AMBERtool script used for analyzing the output trajectory files and generating the 
RMSD of the active site residues during 10 ns simulation.* 
trajin 2QE3_12.md.am8.x 
trajin 2QE3_13.md.am8.x 
trajin 2QE3_14.md.am8.x 
trajin 2QE3_15.md.am8.x 
trajin 2QE3_16.md.am8.x 
trajin 2QE3_17.md.am8.x 
trajin 2QE3_18.md.am8.x 
trajin 2QE3_19.md.am8.x 
trajin 2QE3_20.md.am8.x 
trajin 2QE3_21.md.am8.x 
reference 2QE3_2_mdstart.pdb 
rms reference out pnbCE_362.rms time 0.1 :362 
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rms reference out pnbCE_189.rms time 0.1 :189 
rms reference out pnbCE_218.rms time 0.1 :218 
rms reference out pnbCE_219.rms time 0.1 :219 
rms reference out pnbCE_270.rms time 0.1 :270 
rms reference out pnbCE_310.rms time 0.1 :310 
rms reference out pnbCE_399.rms time 0.1 :399 
 
A.3.5 arrow_mode7.tcl 
*This is a VMD tcl script used to generate the arrow plot for NMA.* 
display resize 1000 1000 
draw color red 
proc vmd_draw_arrow {mol start end {res 28}} { 
 set middle [vecadd $start [vecscale 0.9 [vecsub $end $start]]] 
 graphics $mol cylinder $start $middle radius 0.15 resolution $res filled yes 
 graphics $mol cone $middle $end radius 0.35 resolution $res } 
 
# vmd extension procedure 
# 
# $Id: vmd_draw_delete.tcl,v 1.1 2005/01/03 14:06:39 akohlmey Exp $ 
# replace the default 'draw delete' with a multibple argument 
# (which may even be lists) aware version 
proc vmd_draw_delete {args} { 
    set i 0 
    foreach list $args { 
        if {$i == 0} { 
     lassign $list mol 
            incr i 
        } 
        if {$list == "all"} { 
            graphics $mol delete all 
     return 
        } 
        foreach id $list { 
            graphics $mol delete $id 
        } 
    } 
    return 
} 
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A.4 PROTEIN SEQUENCES 
       1  MTHQIVTTQY GKVKGTTENG VHKWKGIPYA KPPVGQWRFK APEPPEVWED  
[coil_5]  MTHQIVTTQY GKVKGTTENG VHKWKGIPYA KPPVGQWRFK APEPPEVWED  
[coil_21] MTHQIVTTQY GKVKGTTENG VHKWKGIPYA KPPVGQWRFK APEPPEVWED  
 
      51  VLDATAYGPI CPQPSDLLSL SYTELPRQSE DCLYVNVFAP DTPSQNLPVM  
[coil_5]  VLDATAYGPI CPQPS     RQSE DCLYVNVFAP DTPSQNLPVM  
[coil_21] VLDATAYGPI CPQPSDLLSL SYTELPRQSE DCLYVNVFAP DTPSQNLPVM  
 
     101  VWIHGGAFYL GAGSEPLYDG SKLAAQGEVI VVTLNYRLGP FGFLHLSSFD  
[coil_5]  VWIHGGAFYL GAGSEPLYDG SKLAAQGEVI VVTLNYRLGP FGFLHLSSFD  
[coil_21] VWIHGGAFYL GAGSEPLYDG SKLAAQGEVI VVTLNYRLGP FGFLHLSSFD  
 
     151  EAYSDNLGLL DQAAALKWVR ENISAFGGDP DNVTVFGESA GGMSIAALLA  
[coil_5]  EAYSDNLGLL DQAAALKWVR ENISAFGGDP DNVTVFGESA GGMSIAALLA  
[coil_21] EAYSDNLGLL DQAAALKWVR ENISAFGGDP DNVTVFGESA GGMSIAALLA  
 
     201  MPAAKGLFQK AIMESGASRT MTKEQAASTA AAFLQVLGIN ESQLDRLHTV  
[coil_5]  MPAAKGLFQK AIMESGASRT MTKEQAASTA AAFLQVLGIN ESQLDRLHTV  
[coil_21] MPAAKGLFQK AIMESGASRT MTKEQAASTA AAFLQVLGIN ESQLDRLHTV  
 
     251  AAEDLLKAAD QLRIAEKENI FQLFFQPALD PKTLPEEPEK SIAEGAASGI  
[coil_5]  AAEDLLKAAD QLRIAEKENI FQLFFQPALD PKTLPEEPEK SIAEGAASGI  
[coil_21] AAEDLLKAAD QLRIAEKENI FQLFFQPALD PKTLPEEPEK SIAEGAASGI  
 
     301  PLLIGTTRDE GYLFFTPDSD VHSQETLDAA LEYLLGKPLA EKAADLYPRS  
[coil_5]  PLLIGTTRDE GYLFFTPDSD VHSQETLDAA LEYLLGKPLA EKAADLYPRS  
[coil_21] PLLIGTTRDE GYLFFTPDSD VHSQETLDAA LEYLLGKPLA EKAADLYPRS  
 
     351  LESQIHMMTD LLFWRPAVAY ASAQSHYAPV WMYRFDWHPE KPPYNKAFHA  
[coil_5]  LESQIHMMTD LLFWRPAVAY ASAQSHYAPV WMYRFDWHPE KPPYNKAFHA  
[coil_21] LESQIHMMTD LLFWRPAVAY ASAQSHYAPV WMYRFDWHPE KPPYNKAFHA  
 
     401  LELPFVFGNL DGLERMAKAE ITDEVKQLSH TIQSAWITFA KTGNPSTEAV  
[coil_5]  LELPFVFGNL DGLERMAKAE ITDEVKQLSH TIQSAWITFA KTGNPSTEAV  
[coil_21] LELPFVFGNL DGL        ITDEVKQLSH TIQSAWITFA KTGNPSTEAV  
 
     451  NWPAYHEETR ETVILDSEIT IENDPESEKR QKLFPSKGE* 
[coil_5]  NWPAYHEETR ETVILDSEIT IENDPESEKR QKLFPSKGE* 
[coil_21] NWPAYHEETR ETVILDSEIT IENDPESEKR QKLFPSKGE* 
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A.5 DNA SEQUENCES 
       1  ATGACTCATC AAATAGTAAC GACTCAATAC GGCAAAGTAA AAGGCACAAC  
[coil_5]  ATGACTCATC AAATAGTAAC GACTCAATAC GGCAAAGTAA AAGGCACAAC  
[coil_21] ATGACTCATC AAATAGTAAC GACTCAATAC GGCAAAGTAA AAGGCACAAC 
 
      51  GGAAAACGGC GTACATAAGT GGAAAGGCAT CCCCTATGCC AAGCCGCCTG  
[coil_5]  GGAAAACGGC GTACATAAGT GGAAAGGCAT CCCCTATGCC AAGCCGCCTG 
[coil_21] GGAAAACGGC GTACATAAGT GGAAAGGCAT CCCCTATGCC AAGCCGCCTG 
 
     101  TCGGACAATG GCGTTTTAAA GCACCTGAGC CGCCTGAAGT GTGGGAAGAT  
[coil_5]  TCGGACAATG GCGTTTTAAA GCACCTGAGC CGCCTGAAGT GTGGGAAGAT  
[coil_21] TCGGACAATG GCGTTTTAAA GCACCTGAGC CGCCTGAAGT GTGGGAAGAT  
 
     151  GTGCTTGATG CCACAGCGTA CGGCTCTATT TGCCCGCAGC CGTCTGATTT  
[coil_5]  GTGCTTGATG CCACAGCGTA CGGCTCTATT TGCCCGCAGC CGTCT  
[coil_21] GTGCTTGATG CCACAGCGTA CGGCTCTATT TGCCCGCAGC CGTCTGATTT  
 
     201  GCTGTCACTT TCGTATACTG AGCTGCCCCG CCAGTCCGAG GATTGCTTGT  
[coil_5]         CG CCAGTCCGAG GATTGCTTGT  
[coil_21] GCTGTCACTT TCGTATACTG AGCTGCCCCG CCAGTCCGAG GATTGCTTGT 
 
     251  ATGTCAATGT ATTTGCGCCT GACACCCCAA GTAAAAATCT TCCTGTCATG  
[coil_5]  ATGTCAATGT ATTTGCGCCT GACACCCCAA GTAAAAATCT TCCTGTCATG  
[coil_21] ATGTCAATGT ATTTGCGCCT GACACCCCAA GTAAAAATCT TCCTGTCATG  
 
     301  GTGTGGATTC ACGGAGGCGC TTTTTATCTA GGAGCGGGCA GTGAGCCATT  
[coil_5]  GTGTGGATTC ACGGAGGCGC TTTTTATCTA GGAGCGGGCA GTGAGCCATT  
[coil_21] GTGTGGATTC ACGGAGGCGC TTTTTATCTA GGAGCGGGCA GTGAGCCATT 
 
     351  GTATGACGGA TCAAAACTTG CGGCACAGGG AGAAGTCATT GTCGTTACAT  
[coil_5]  GTATGACGGA TCAAAACTTG CGGCACAGGG AGAAGTCATT GTCGTTACAT  
[coil_21] GTATGACGGA TCAAAACTTG CGGCACAGGG AGAAGTCATT GTCGTTACAT  
 
     401  TGAACTATCG GCTGGGGCCG TTTGGCTTTT TGCACTTGTC TTCATTTAAT  
[coil_5]  TGAACTATCG GCTGGGGCCG TTTGGCTTTT TGCACTTGTC TTCATTTAAT 
[coil_21] TGAACTATCG GCTGGGGCCG TTTGGCTTTT TGCACTTGTC TTCATTTAAT  
 
     451  GAGGCGTATT CTGATAACCT TGGGCTTTTA GACCAAGCCG CCGCGCTGAA  
[coil_5]  GAGGCGTATT CTGATAACCT TGGGCTTTTA GACCAAGCCG CCGCGCTGAA  
[coil_21] GAGGCGTATT CTGATAACCT TGGGCTTTTA GACCAAGCCG CCGCGCTGAA  
 
     501  ATGGGTGCGA GAGAATATTT CAGCGTTTGG CGGTGATCCC GATAACGTAA  
[coil_5]  ATGGGTGCGA GAGAATATTT CAGCGTTTGG CGGTGATCCC GATAACGTAA  
[coil_21] ATGGGTGCGA GAGAATATTT CAGCGTTTGG CGGTGATCCC GATAACGTAA  
 
     551  CAGTATTTGG AGAATCCGCC GGCGGGATGA GCATTGCCGC GCTGCTTGCT  
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[coil_5]  CAGTATNNGG AGAATCCGCC GGCGGGATGA GCATTGCCGC GCTGCTTGCT 
[coil_21] CAGTATTTGG AGAATCCGCC GGCGGGATGA GCATTGCCGC GCTGCTTGCT  
 
     601  ATGCCTGCGG CAAAAGGCCT GTTCCAGAAA GCAATCATGG AAAGCGGCGC  
[coil_5]  ATGCCTGCGG CAAAAGGNCT GTTCCAGAAA GCAATCATGG NAAGCGGCGC  
[coil_21] ATGCCTGCGG CAAAAGGCCT GTTCCAGAAA GCAATCATGG AAAGCGGCGC  
 
     651  TTCTCGAACG ATGACGAAAG AACAAGCGGC GAGCACCTCG GCAGCCTTTT  
[coil_5]  TTCTCGAACG ATGACGAAAG AACAAGCGGC GAGCACCTCG GCAGNCTTTT  
[coil_21] TTCTCGAACG ATGACGAAAG AACAAGCGGC GAGCACCTCG GCAGCCTTTT  
 
     701  TACAGGTCCT TGGGATTAAC GAGGGCCAAC TGGATAAATT GCATACGGTT  
[coil_5]  TACAGGTCCT TGGGATTAAC GAGGGCCAAC TGGATAAATT GCATACGGTT 
[coil_21] TACAGGTCCT TGGGATTAAC GAGGGCCAAC TGGATAAATT GCATACGGTT  
 
     751  TCTGCGGAAG ATTTGCTAAA AGCGGCTGAT CAGCTTCGGA TTGCAGAAAA  
[coil_5]  TCTGCGGAAG ATTTGCTAAA AGCGGCTGAT CAGCTTCGGA TTGCAGAAAA  
[coil_21] TCTGCGGAAG ATTTGCTAAA AGCGGCTGAT CAGCTTCGGA TTGCAGAAAA  
 
     801  AGAAAATATC TTTCAGCTGT TCTTCCAGCC CGCCCTTGAT CCGAAAACGC  
[coil_5]  AGAAAATATC TTTCAGCTGT TCTTCCAGCC CGCCCTTGAT CCGAAAACGC  
[coil_21] AGAAAATATC TTTCAGCTGT TCTTCCAGCC CGCCCTTGAT CCGAAAACGC  
 
     851  TGCCTGAAGA ACCAGAAAAA GCGATCGCAG AAGGGGCTGC TTCCGGTATT  
[coil_5]  TGCCTGAAGA ACCAGAAAAA GCGATCGCAG AAGGGGCTGC TTCCGGTATT  
[coil_21] TGCCTGAAGA ACCAGAAAAA GCGATCGCAG AAGGGGCTGC TTCCGGTATT  
 
     901  CCGCTATTAA TTGGAACAAC CCGTGATGAA GGATATTTAT TTTTCACCCC  
[coil_5]  CCGCTATTAA TTGGAACAAC CCGTGATGAA GGATATTTAT TTTTCACCCC  
[coil_21] CCGCTATTAA TTGGAACAAC CCGTGATGAA GGATATTTAT TTTTCACCCC 
 
     951  GGATTCAGAC GTTCATTCTC AGGAAACGCT TGATGCAGCG CTCGAGTATT  
[coil_5]  GGATTCAGAC GTTCATTCTC AGGAAACGCT TGATGCAGCG CTCGAGTATT  
[coil_21] GGATTCAGAC GTTCATTCTC AGGAAACGCN TGATGCAGCG CTCGAGTATT  
 
    1001  TACTAGGGAA GCCGCTGGCA GAGAAAGTTG CCGATTTGTA TCCGCGTTCT  
[coil_5]  TACTAGGGAA GCCGCTGGCA GAGAAAGTTG CCGATTTGTA TCCGCGTTCT  
[coil_21] TACTAGGGAA GCCGCTGGCA GAGAAAGTTG CCGATTTGTA TCCGCGTTCT  
 
    1051  CTGGAAAGCC AAATTCATAT GATGACTGAT TTATTATTTT GGCGCCCTGC  
[coil_5]  CTGGAAAGCC AAATTCATAT GATGACTGAT TTATTATTTT GGCGCCCTGC  
[coil_21] CTGGAAAGCC AAATTCATAT GATGACTGAT TTATTATTTT GGCGCCCTGC 
 
    1101  CGTCGCCTAT GCATCCGCAC AGTCTCATTA CGCCCCTGTC TGGATGTACA  
[coil_5]  CGTCGCCTAT GCATCCGCAC AGTCTCATTA CGCCCCTGTC TGGATGTACA 
[coil_21] CGTCGCCTAT GCATCCGCAC AGTCTCATTA CGCCCCTGTC TGGATGTACA  
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    1151  GGTTCGATTG GCACCCGAAG AAGCCGCCGT ACAATAAAGC GTTTCACGCA  
[coil_5]  GGTTCGATTG GCACCCGAAG AAGCCGCCGT ACAATAAAGC GTTTCACGCA  
[coil_21] GGTTCGATTG GCACCCGAAG AAGCCGCCGT ACAATAAAGC GTTTCACGCA  
 
    1201  TTGGAGCTTC CTTTTGTCTT TGGAAATCTG GACGGATTGG AACGAATGGC  
[coil_5]  TTAGAGCTTC CTTTTGTCTT TGGAAATCTG GACGGATTGG AACGAATGGC  
[coil_21] TTAGAGCTTC CTTTTGTCTT TGGAAATCTG GACGGATTG  
 
    1251  AAAAGCGGAG ATTACGGATG AGGTGAAACA GCTTTCTCAC ACGATACAAT  
[coil_5]  AAAAGCGGAG ATTACGGATG AGGTGAAACA GCTTTCTCAC ACGATACAAT 
[coil_21]    ATTACGGATG AGGTGAAACA GCTTTCTCAC ACGATACAAT  
 
    1301  CAGCGTGGAT CACGTTCGCC AAAACAGGAA ACCCAAGCAC CGAAGCTGTG  
[coil_5]  CAGCGTGGAT CACGTTCGCC AAAACAGGAA ACCCAAGCAC CGAAGCTGTG  
[coil_21] CAGCGTGGAT CACGTTCGCC AAAACAGGAA ACCCAAGCAC CGAAGCTGTG  
 
    1351  AATTGGCCTG CGTATCATGA AGAAACGAGA GAGACGCTGA TTTTAGACTC  
[coil_5]  AATTGGCCTG CGTATCATGA AGAAACGAGA GAGACGCTGA TTTTAGACTC  
[coil_21] AATTGGCCTG CGTATCATGA AGAAACGAGA GAGACGCTGA TTTTAGACTC 
 
    1401  AGAGATTACG ATCGAAAACG ATCCCGAATC TGAAAAAAGG CAGAAGCTAT  
[coil_5]  AGAGATTACG ATCGAAAACG ATCCCGAATC TGAAAAAAGG CAGAAGCTAT  
[coil_21] AGAGATTACG ATCGAAAACG ATCCCGAATC TGAAAAAAGG CAGAAGCTAT 
 
    1451  TCCCTTCAAA AGGAGAATAA 
[coil_5]  TCCCTTCAAA AGGAGAATAA 
[coil_21] TCCCNTCAAN AGGAGAATAA 
 
 
 
